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Background: Sleep disturbances are common in children and young people with 
Tourette syndrome and chronic tic disorders (TS/CTD), although at present it is unclear 
whether any particular sleep problems could be considered typical of these conditions. It is 
also not known whether any identified patient characteristics, neurodevelopmental or 
psychiatric factors are associated with their presence in this group.  
Objectives: This review aimed to systematically explore types and frequency of sleep 
problems in children with TS/CTD.  It aimed to examine the heterogeneity of previous studies 
in terms of sample characteristics and assessment methods and consider methodological 
quality of included studies. 
Methods: The Psycinfo, Ovid Medline, Embase and Web of Science databases were 
searched using a range of terms relating to tics, sleep and co-existing psychopathology. Studies 
were considered if they met a pre-determined set of criteria, including a sample of children 
with TS/CTD (n>5) for whom sleep disturbance was measured. 14 studies met criteria for 
inclusion in the review. 
Results: Overall, this review supported the high prevalence of sleep difficulties in 
children with TS/CTD, although rates varied widely from 17% to 80.4% (Interquartile Range 
(IQR) =21%-48%). A number of studies reported on other factors affecting sleep in this patient 
group including comorbidity, medication use and sample-related factors, such as age and 
gender. Studies varied in terms of methodology, sample and quality. 
Conclusions:  The high rates of sleep problems in children with TS/CTD identified in this 
review, which was based on a small yet heterogeneous sample of papers, highlights the need 
for continued research in this area. The potential moderating factors and associated difficulties 
discussed here should be considered further to enhance understanding of the aetiology and 










It is widely recognised that children and young people with Tourette syndrome (TS) 
and chronic tic disorders (CTD) frequently experience difficulties sleeping (Kirov, Becker & 
Rothenberger, 2014). However, as yet the nature and specificity of these problems have not 
been identified, with a wide range of disturbances being reported in previous literature (e.g. 
Storch, Milsom, Lack, Pence, Geffken, Jacob et al., 2009). It is unclear whether this reflects true 
heterogeneity of the difficulties or methodological variation between studies. The present 
review aims to provide a comprehensive overview of existing research about sleep in TS/CTD 




Sleep is an active physiological state during which information acquired over waking 
hours is processed (Astill, Van der Heijden, Van Ijzendoorn & Van Someren, 2012). It is 
characterised by changes to cardiovascular and neuronal functioning, posture, mobility, level 
of alertness, eyelid movement, respiration and body temperature (Gregory & Sadeh, 2016). 
Sleep is understood to be comprised of different stages beginning with non-rapid eye 
movement (N-REM), which incorporates three progressively deeper states from one and two 
to the third stage, known as slow wave sleep (SWS). The final, quite distinct, stage is rapid eye 
movement (REM) sleep. During a sleep period these stages occur in repeating cycles 
(Ashworth, Hill, Karmiloff-Smith & Dimitriou, 2014).  
During typical development sleep duration, patterns, architecture and stage 
distribution change in a maturational process which depends on age and central nervous 
system (CNS) development (MacLean, Fitzgerald & Waters, 2015). Thus, sleep difficulties might 
be expected in disorders involving altered CNS function including neurodevelopmental and 
neuropsychiatric conditions. However, sleep is a complex and vulnerable state which can be 
affected by a wide range of physiological, psychological and environmental factors (Gregory & 
Sadeh, 2016). Sleep problems can present as clinically significant conditions (e.g. 
hypersomnolence or circadian rhythm disorders; American Psychiatric Association, 2013) or as 
sub-clinical disturbances. As mentioned, sleep disturbance often occurs alongside, or is 
symptomatic of, conditions such as depression (Devnani & Hedge, 2015) and attention deficit 
hyperactivity disorder (ADHD; Astill et al., 2012). These disorders and sleep influence each 
other bidirectionally and can risk developing into a ‘vicious cycle’ (i.e. poor sleep worsens 
depression symptoms, which impacts sleep; Kahn, Sheppes & Sadeh, 2013).  
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Sleep difficulties affect daytime functioning, being predictive of emotional and 
behavioural difficulties as well as cognitive and academic performance (Wang, Isensee, Becker, 
Wong, Eastwood, Huang et al., 2016; Axelsson, Williams & Horst, 2016; Blechner & Williamson, 
2016). Identifying and managing sleep difficulties promptly is therefore crucial to minimise 
their impact on psychosocial functioning. When sleep problems co-occur with 
neurodevelopmental or psychiatric disorders their presentation is often thought to be 
disorder-specific, possibly reflecting varying aetiological factors (Blackmer & Feinstein, 2016).  
Understanding different causes of sleep problems might facilitate the development of tailored 
interventions to improve sleep. Currently however, few clear disorder-specific sleep patterns 
are known and studies exploring these often reach conflicting conclusions. For instance, while 
ADHD is often thought to be characterised by frequent periodic limb movements in sleep 
(PLMS; Sadeh, Pergamin & Bar-Haim, 2006), this finding is not universal (Choi, Yoon, Kim, 
Chung & Yoo, 2010; Diaz-Roman, Hita-Yanez & Buela-Casal, 2016).  
Sleep problems can be treated in various ways with adherence to good sleep hygiene 
principles (e.g. regular bedtime routines) being well-supported (Kaczor & Skalski, 2016). 
However, in children with additional difficulties these behavioural strategies may need to be 
adapted or augmented (e.g. including relaxation for anxiety; Ramtekkar & Ivanenko, 2015). 
Evidence for pharmacological treatments, regardless of the presence of other disorders, is 
mixed. For instance, while Melatonin reduces sleep latency it does not seem to impact sleep 
duration (Gringras, Gamble, Jones, Wiggs, Williamson, Sutcliffe et al., 2012). Furthermore, 
certain medications such as Selective Serotonin Reuptake Inhibitors (SSRIs), which are 
commonly prescribed to manage anxiety, can disrupt sleep so should be used cautiously in 
clinical groups predisposed to sleep problems (Kaczor & Skalski, 2016; Ramtekkar & Ivanenko, 
2015; Mulraney, Giallo, Lycett, Mensah & Sciberras, 2016). 
2.1.2 Sleep assessment  
Sleep is therefore a complex phenomenon involving physiological and behavioural 
changes and can be assessed in various ways, broadly categorised into objective and subjective 
methods (Gregory & Sadeh, 2012). Polysomnography (PSG) is recognised as the ‘gold standard’ 
of objective sleep assessment and involves laboratory monitoring of neurophysiological and 
cardiorespiratory variables (Sadeh, 2015). PSG typically lasts one or two nights and generates 
extremely detailed information to enable clinical diagnosis of sleep disorders. However, it is 
costly and requires sleeping in a laboratory so is not especially representative of natural sleep 
patterns. A more naturalistic objective approach is actigraphy; this is conducted using a 
wristwatch-like device that continuously measures body movements to allow inferences to be 
made about sleep-wake patterns. It can be used in children’s own homes and for periods of 
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several weeks, therefore is more reflective of typical sleep than PSG. However, it is less 
detailed and can be affected by movement artefacts. For this reason, it is proposed that 
outputs should be carefully monitored and assessed for accuracy which can be time-
consuming (Meltzer, Wong, Biggs, Traylor, Kim, Bhattacharjee et al., 2016). Both approaches 
provide a range of sleep parameters including total sleep time, duration, number of stages, 
cycles and sleep efficiency (i.e. the amount of time in bed spent asleep). However, they do not 
generate information regarding children- or parent-perception of sleep difficulties. For this, 
subjective measures such as sleep diaries and questionnaires should be used.  
Sleep diaries typically include information about sleep schedule and behaviours that 
might affect sleep. However they are not standardised and rarely generate information about 
other aspects of functioning or wellbeing. Questionnaires are a time- and cost-effective 
standardised way to gather this information. A range of validated sleep assessment 
questionnaires exist, however many rely solely on parent-report. This can be problematic as 
parent- and child-reports of sleep variables are often discrepant (Ji & Liu, 2016; Storch, 
Murphy, Lack, Geffken, Jacob & Goodman, 2008). Ideally, multiple informants should be 
consulted whenever possible. Overall, subjective measures are flawed due the complexity of 
sleep, as this makes it difficult to measure by pre-set criteria (Ji & Liu, 2016). Questionnaires 
can also be affected by factors including expectations, psychological influences and responder 
bias (Danker-Hopfe, 2011). Objective and subjective outcomes tend to correlate weakly 
(Tremaine, Dorrian & Blunden, 2010; Choi et al., 2010), suggesting they measure different 
aspects of sleep. Using multiple assessment methods is therefore recommended to produce a 
comprehensive overview of sleep difficulties and their functional impact (Gregory & Sadeh, 
2016). 
2.2 Tourette syndrome and chronic tic disorders 
Gilles de la Tourette syndrome (TS) is a complex neuropsychiatric condition that was 
first described by Neurologist Georges Gilles de la Tourette in an 1885 paper on nine patients 
with a ‘malady of tics’, including involuntary movements and sounds (Lajonchere, Nortz & 
Finger, 1996). Current diagnostic manuals (DSM-V; American Psychiatric Association, 2013) 
characterise TS by the presence of two or more motor tics and at least one phonic tic that have 
been present for at least one year, begin before 18 years of age, and are not caused by 
medications or health conditions. People with either motor or phonic tics who meet these 
criteria can be diagnosed with chronic tic disorders (CTD; American Psychiatric Association, 
2013). Overall prevalence estimates for TS in childhood are around 0.77% (Knight, Steeves, 
Day, Lowerison, Jette & Pringesheim, 2012) although TS may present more mildly in the 
community than in clinics, thus potentially making this an underestimation (Robertson, 2000). 
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TS/CTDs are approximately four times more common in males than females (Freeman, Fast, 
Burd, Kerbeshian, Robertson, & Sandor, 2000). 
Tics are brief sudden movements or sounds sometimes preceded by a premonitory 
sensation (‘urge’). They are suggestible, suppressible and typically occur with variable 
frequency (‘waxing and waning’; Kumar, Trescher & Byler, 2016). Tics usually first appear 
during childhood with a mean emergence around six years of age before peaking in severity 
around 10-12 years of age. They tend to improve in adolescence, often disappearing by 
adulthood (Bloch & Leckman, 2009; Freeman et al., 2000). Tics can be simple or complex. 
‘Simple’ tics involve single muscles or sounds (e.g. eye-blinking, coughing, throat clearing), 
while ‘complex’ tics include movement of multiple muscles or body parts, speaking phrases or 
strings of sounds. Complex tics can also include copying other people’s movements 
(‘echopraxia’), copying of speech (‘echolalia’) or making obscene gestures or comments 
(‘copraphenomena’). Tics can negatively impact on quality of life with physical pain following 
certain motor tics, and phonic tics or copraphenomena often causing embarrassment and 
distress (Eapen, Cavanna & Robertson, 2016).  
In line with its complex nature, the aetiology of TS is thought to be multifactorial 
including genetic vulnerability (Forde, Kanaan, Widomska, Padmanabhuni, Nespoli, Alexander 
et al., 2016), neuroinflammatory and autoimmune processes (Spinello, Laviola & Macri, 2016), 
pre- and peri-natal insults (Ludolph, Roessner, Munchau & Muller-Vahl, 2012) and 
androgenous influences (Smith & Dahodwala, 2014). However, at present the mechanisms 
through which different factors may combine to cause TS are unclear. Furthermore, despite 
being recognised as a neurological disorder, the neuroanatomical basis of TS is not well 
understood with mixed findings regarding the brain regions involved in its development and 
maintenance. This may be due to methodological differences across studies as well as the 
phenotypic complexity of TS (Forde, Zwiers, Naaijen, Akkermans, Openneer, Visscher et al., 
2017). The most consistent evidence associates TS with changes in dopamine-mediated neural 
regions involved in inhibition, habit formation and reward, which encompass a cortico-striatal-
thalamo-cortical network (Mink, 2001). Enhanced connectivity between the striatum and 
thalamus and motor, frontal, parietal and temporal regions is one factor thought to underpin 
tic genesis (Greene, Schlagger & Black, 2015). Despite evidence for dopaminergic changes in 
TS, patients also show altered transmission of serotonin, glutamate, and gamma-aminobutyric 
acid (GABA; Paschou, Fernandez, Sharp, Heiman & Hoekstra, 2013), thus implicating a wider 
neural network than only dopaminergic regions in its pathophysiology (Mink, 2001). Despite 
their clear neurobiological basis, tics are also exacerbated by environmental and contextual 
factors (e.g. stress; Gunduz & Okun, 2016). Stressful events are thought to exacerbate tics both 
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physiologically through activation of the hypothalamic-pituitary-adrenal (HPA) axis, and 
behaviourally via impaired capacity for suppression (Godar & Bortolato, 2016; Tagwerker & 
Walitza, 2016). Overall therefore, the aetiology of TS is poorly understood with different 
neural circuits and environmental factors likely to be implicated in different symptoms which 
may change during development. 
In line with the varied aetiology and neurobiology of TS, and to facilitate thinking 
around its heterogeneous presentation, attempts have been made to subtype TS. A common 
distinction differentiates between ‘pure TS’ (tics only), ‘TS plus’ (TS with echo- and 
copraphenomena) and ‘full blown TS’ (‘TS plus’ with comorbid neurodevelopmental and/or 
psychiatric difficulties; Robertson & Baron-Cohen, 1998). Within ‘full blown TS’ comorbidities 
are wide-ranging (Kumar et al., 2016) and include neurodevelopmental (e.g. autism spectrum 
disorder; ASD), anxiety (e.g. obsessive compulsive disorder; OCD), mood (e.g. depression) and 
behavioural disorders (e.g. ADHD). A previous systematic review found that the most common 
comorbidities, presenting in 40-80% of patients, were behavioural disorders (e.g. ADHD), 
followed by OCD which occurs in 11-80% of patients (Ferreira, Pio-Abreu & Januario, 2014).  
Comorbidity is a key determinant of health-related quality of life for people with 
TS/CTD who may require extra support to understand and manage these additional conditions 
or difficulties (e.g. sleep disturbance; Cavanna, David, Bandera, Termine, Balottin, Schrag et al., 
2013). In line with this, researchers have begun to explore interactions between TS/CTD and 
other disorders. Much of this research has considered neurobiological profiles (Sambrani, 
Jakubovski & Müller-Vahl, 2016), with initial genetic and neuroimaging studies suggesting 
more similarities between TS/CTD and OCD than TS/CTD and ADHD (Greene, Williams, Koller, 
Schlagger & Black, 2016). This might suggest that OCD and TS/CTD could be causally linked, 
while ADHD is a distinct but common comorbidity. This work is preliminary but may impact on 
management and intervention of each disorder within the context of tics, as well as co-
occurring problems such as poor sleep. 
2.3 Sleep in TS/CTD 
Sleep difficulties have been identified in TS/CTD patients (Kirov et al, 2014), however, 
in line with research into other disorders, their frequency, nature and aetiology is unclear 
(Kirov et al., 2014). A fairly consistent finding is that TS/CTD patients exhibit a high level of 
movement during sleep (Cohrs, Rasch, Altmeyer, Kinkelbur, Kostanecka, Rothenberger et al., 
2001). It is unclear whether this represents a disorder-specific sleep difficulty, or whether 
movements are caused by transdiagnostic influences such as medication use (Arana-Lechuga, 
Sanchez-Escandon, Santiago-Trevino, Castillo-Montoya, Teran-Perez & Velaquez-Moctezuma, 
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2008). Furthermore, in samples of children with TS/CTD and comorbid ADHD, sleep difficulties 
can almost entirely be accounted for by ADHD symptoms, suggesting they may reflect 
comorbid factors rather than being characteristic of TS/CTD per se (Freeman, 2007). 
Disorder-specific hypotheses draw on observations of shared neurobiological changes 
between sleep disturbance and TS/CTD. For instance, certain genes implicated in the aetiology 
of TS/CTD also cause sleep-related movement problems (e.g. PLMS; Muller, Voderholzer, Kurtz 
& Straube, 1994). Neurochemically, as previously discussed, dopamine is thought to be 
implicated in TS/CTD development (Mink, 2001). Sleep disturbances can be treated in TS 
patients with pharmacological agents that block dopaminergic systems, suggesting a common 
dopaminergic basis for sleep- and movement-disorders (Arana-Lechuga et al., 2008). 
Furthermore, reduced intracortical inhibition (i.e. increased arousal) of motor pathways is a 
common factor in TS/CTD and sleep disturbance (Happe & Trenkwalder, 2002). Sleep 
difficulties in TS/CTD appear to differ based on individual factors such as age and gender. They 
appear to be less prevalent in adults than children although it is unclear whether this is linked 
to changes in tic-related pathophysiology (i.e. hormones, neurological structure or function), 
improved management of other factors (i.e. receiving treatment for anxiety) or behavioural 
changes (i.e. better sleep hygiene; Freeman, 2007). Sleep problems may also be more common 
in females than males with TS, which could support a role for hormonal processes in 
development of sleep disturbance (Sambrani et al., 2016) or reflect gender-specific patterns of 
comorbidity or tic severity (Lichter & Finnegan, 2015).   
Alternatively, sleep disturbance in TS/CTD may be caused by medication-use. 
Pharmacotherapy is the most common treatment for TS/CTD and the most frequently 
prescribed medications (Clonidine, Aripiprazole and Risperidone; Rickards, Cavanna & Worrall, 
2012) all affect sleep (Hollis, Pennant, Cuenca, Glazebrook, Kendall, Whittington et al., 2016). 
Furthermore, concerns about sleep disturbance are commonly cited by parents and young 
people as a reason for refusing psychopharmacological treatment (Cuenca, Glazebrook, 
Kendall, Hedderly, Heyman, Jackson et al., 2015).  
It is therefore unclear whether sleep difficulties are linked directly with TS/CTD 
pathology (at a hormonal, genetic or neuroanatomical level), whether they are caused by 
comorbid neurodevelopmental difficulties, pharmacological treatments or result from a 
combination of these factors (Kirov et al., 2014). It would be helpful to comprehensively 
consider the characteristics of sleep in varied samples of children with TS/CTD to see if clear 




2.4 Review aims 
Evidence suggests that people with TS/CTD experience sleep difficulties. However, as 
previously mentioned, to the author’s knowledge, no formal systematic review has yet been 
undertaken to fully summarise this area. The current review aims to provide this overview and 
has two main aims:  
1. To explore the types and frequency of sleep difficulties in children with TS/CTD. 























3. Method  
3.1 Literature search 
This review was based on a systematic search of papers published before May 2016. 
The search was conducted in line with the guidelines of PRISMA (the Preferred Reporting Items 
for Systematic reviews and Meta-Analyses; Moher, Liberati, Tetzlaff & Altman, 2009) using two 
approaches: 
Firstly, a computer search was conducted of the Psycinfo, Medline (ovid), Embase and 
Web of Science online databases. This search combined four separate components: 
1. Tourette* Syndrome (OR) Tourette* (OR) tic* (OR) tic disorder (OR) chronic tics (OR) chronic 
tic disorder (OR) transient tic disorder 
(AND) 
2. Sleep (OR) sleep disorder (OR) sleep behavi?r (OR) sleep disturbance (OR) sleep difficult* 
(AND) 
3. Actigraph* (OR) polysomnograph* (OR) diary (OR) questionnaire (OR) self-report (OR) 
parent-report (OR) objective (OR) subjective  
(AND) 
4. Comorbid* (OR) Psycholog* (OR) Psychiat* (OR) disorder* (OR) mental health (OR) mood 
disorder* (OR) anx* (OR) dep* (OR) neurodevelopment* 
 
Secondly, relevant journals were hand searched, along with reference lists of relevant 
papers and the bibliographies of frequently cited researchers.   
Following this initial search, each stage of the review was conducted independently by 
two researchers (CH & ST) to reduce bias. Any disputes were raised with a third member of the 
review team if necessary. After the removal of duplicate papers (see Figure 1), 892 abstracts 
were screened for the following inclusion criteria: i) sample size ≥5 participants; ii) mean age of 
participants <18 years; iii) inclusion of participants with Tourette syndrome or chronic tics; iv) 
inclusion of a measure of sleep difficulty; v) empirically-based (i.e. not literature reviews) and 
peer reviewed (i.e. not dissertations or conference proceedings); vi) published in English. 
Based on the inclusion criteria 77 studies were identified for more in-depth review. Of 
these, 63 papers were excluded with the following justifications: i) no clear measurement of 
sleep difficulty; ii) sample size <5; iii) mean age >18; iv) not being empirically-based or 
published in a peer-reviewed format; v) not being written in English. 8 papers could not be 
accessed by the researcher. 
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Figure 1: PRISMA flowchart 
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3.2 Data extraction 
For eligible articles, data was extracted regarding the sample characteristics, study 
methods and results.  
3.2.1 Sample characteristics 
Information about sample characteristics was extracted from each paper relating to 
number of participants with TS/CTD, details of any comparison groups, recruitment site, age, 
gender and medication status of participants.  
3.2.2 Methods and results 
Data was extracted regarding methods used to measure sleep in each study, types of 
sleep difficulty assessed, main results and any additional relevant findings. 
3.3 Quality assessment 
Included articles were assessed for their methodological quality. As there is no agreed 
quality assessment tool for evaluating observational and prevalence studies (Mallen, Peat & 
Croft, 2006), a novel measure was developed drawing on criteria outlined by Loney, Chambers, 
Bennett, Roberts & Stratford (1998), Downs & Black (1998) and the Centre for Reviews and 
















Details of the 14 eligible studies are presented in Tables 1 and 2. 
4.1 Participants 
4.1.1 Recruitment source for TS/CTD participants 
Included studies used a combination of clinical, convenience and community sampling 
methods. 12 studies (85%) recruited TS/CTD participants solely or partially from clinical 
services. Most of these were specialised university hospital clinics (Allen, Singer, Brown & 
Salam, 1992; Barabas & Matthews, 1984; Ghosh, Rajan, Das, Datta, Rthner & Erenberg, 2014; 
Kirov, Banaschewski, Uebel, Kinkelbur & Rothenberger, 2007a; Kirov, Kinkelbur, Banaschewski 
& Rothenberger, 2007b, Kostanecka-Endress, Banaschewski, Wüllner, Lichtblau, Cohrs, Rüther 
et al., 2003; Modafferi, Stornelli, Chiarotti, Cardona & Bruni, 2016; Mol Debes, Hjalgrim & 
Skov, 2008; Saccomani, Fabiana, Manuela & Giambattista, 2005; Stephens, Chung, Jovanovic, 
Guerra, Stephens, Sandor et al., 2007; Storch, Milsom, Lack, Pence, Geffken, Jacob et al., 2009 
& Teive, Germiniani, Della Coletta & Werneck, 2001). Two studies (14%) used a charity to 
recruit some or all TS/CTD participants (Allen et al., 1992; Wand, Matazow, Shady, Furer & 
Staley, 1993). One study (7%) did not explicitly state how data was collected, but appeared to 
be a clinic-based project retrospectively exploring sleep using historical data (Hashimoto, 
Endo, Fukuda, Hiura, Kawano, Suzue et al., 1981).  
4.1.2 Sample characteristics 
4.1.2.1 Size 
Sample sizes varied widely from nine (Hashimoto et al., 1981) to 314 participants (Mol 
Debes et al., 2008). The IQR for sample size was 42-237 participants.  
4.1.2.2 Age 
Age ranges were reported for 12 of the included studies (85%). All samples had a mean 
age under 18 years, but four studies included older participants up to 20 years (Mol Debes et 
al., 2008; Saccomani et al., 2005), 21 years (Ghosh et al., 2014) and 60 years (Tieve et al., 
2001). Another study (Wand et al., 1993), included separate child and adult samples from 







All of the included studies commented on gender distribution of the sample. 13 
studies included both male and female participants, with proportions ranging from 63.6% male 
and 36.4% female (Tieve et al., 2001) to 100% male (Allen et al., 1992).  
4.1.2.4 Medication status 
Medication status of participants was reported for seven of the included studies (50%; 
Allen et al., 1992; Kirov et al., 2007a; Kirov et al., 2007b; Kostanecka-Endress et al., 2003; 
Modafferi et al., 2016; Mol Debes et al., 2008 & Stephens et al., 2007) Of these, three reported 
that participants took medications during the study or did not state a medication-free period 
(Allen et al., 1992; Modafferi et al., 2016; Mol Debes et al., 2008). One study (Allen et al., 
1992), differentiated between participants taking different amounts of medication. The 
remaining four had a pre-study medication-free period from five days to six weeks (Kirov et al., 
2007a; Kirov et al., 2007b; Kostanecka-Endress et al., 2003; Stephens et al., 2007). 
4.1.2.5 Tic disorder group characteristics  
Of the 14 included studies, 13 (93%) had a ‘pure TS’ sample, or a TS sample without 
comorbidity described (Allen et al., 1992; Barabas & Matthews, 1984; Ghosh et al., 2014; 
Hashimoto et al., 1981; Kirov et al., 2007b; Kostanecka-Endress et al., 2003; Modafferi et al., 
2016; Mol Debes et al., 2008; Saccomani et al., 2005; Stephens et al., 2013; Storch et al., 2009; 
Teive et al., 2001 & Wand et al., 1993). The remaining study (Kirov et al., 2007a), compared 
participants with comorbid TS+ADHD to healthy controls. Of the 13 studies with ‘pure TS’ 
samples, three distinguished between TS and CTD (Modafferi et al., 2016; Saccomani et al., 
2005; Teive et al., 2001), one included TS-only and TS+patient- or family-migraine (Barabas & 
Matthews. 1984), and five had both TS-only and TS+ADHD groups (Allen et al., 1992; Ghosh et 
al., 2014; Kirov et al., 2007a; Kirov et al., 2007b & Stephens et al., 2013).  
4.1.2.6 Control group 
Of the included studies, eight had at least one non-TS/CTD group (57%; Allen et al., 
1992; Hashimoto et al., 1981; Kirov et al., 2007a; Kirov et al., 2007b; Kostanecka-Endress et al., 
2003; Modafferi et al., 2016; Saccomani et al., 2005; Stephens et al., 2007). Of these, five had 
one comparison while the remaining three included two control groups (Allen et al., 1992; 
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Kirov et al 
(2007a) 
 
TS+ADHD=19 HC=19 TS+ADHD: Specialist 
clinic 
HC: friends and 





% M; 5.26% F 
HC= 89.47% M; 
10.53% F 
63.16% of TS+ADHD pps 
took medication; all had 
7 medication-free days 
prior to study. 
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HC=8-15.6  (11.58/2.25) 
TS-only= 88.89% 
M; 11.11% F 
TS+ADHD=94.44
% M; 5.56 % F 
ADHD-
only=94.44% M; 
5.56 % F 
HC=88.89% M; 
11.11% F 
72.22% of TS+ADHD & 
ADHD-only and 61.11% 
of TS-only children were 
medicated; all had 5-14 
medication-free days 
prior to study. 
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Kostanecka-
Endress et al 
(2003) 






29.42 % F 
HC=75% M; 25% 
F 
58.83% of pps had been 
medicated; all had at 
least 14 medication-free 
days prior to study. 
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30.56% of TS pps were 
taking medication for tic 
management at the time 
of the study 
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Mol Debes et 
al (2008) 
TS=314 N/A Specialist clinic 5.3-20 (12.4) 81.9% M; 18.1% 
F 
7.7%=methylphenidate 
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Storch et al 
(2009) 
TS/CTD=56 N/A Specialist clinic 7-17 (11.46 +- 2.63) 71.42% M; 
28.58% F 
N/R 7 






N/A Specialist clinic 3-60 (13.5) 63.6% M; 36.4% 
F 
N/R 4 






Of group <18, mean=11.9 
(2.9) 
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Table 2 includes information about the methods used to assess sleep. For one study 
(Barabas & Matthews, 1984), methodology was not discussed in sufficient detail to be included 
here. 
4.2.1 Subjective methods 
Subjective sleep measures were used in nine of the 14 studies (64%). Methods 
included parent report or interview (n=1; Saccomani et al., 2005), review of clinic records (n=1; 
Teive et al., 2001) and questionnaires (n=7). Of the questionnaire studies, three developed 
novel measures (Ghosh et al., 2014; Modafferi et al., 2016; Wand et al., 1993), while four used 
or adapted validated scales (Allen et al., 1992; Kostanecka-Endress et al., 2003; Mol Debes et 
al., 2008; Storch et al., 2009). These included the Sleep Behaviour Questionnaire (Simonds & 
Parraga, 1982); the sleep scale of the Children’s Behaviour Checklist (CBCL; Achenbach & 
Rescorla, 2011), and items from the Multidimensional Anxiety Scale for Children (MASC; 
March, 1998). Four of the seven questionnaire studies (58%) used only parent-report 
measures (Allen et al., 1992; Kostanecka-Endress et al., 2003; Modafferi et al., 2016; Mol 
Debes et al., 2008), while the remaining three (42%) also asked children about their sleep 
(Ghosh et al., 2014; Storch et al., 2009; Wand et al., 1993). No studies used child-report only. 
4.2.1.2 Types of sleep difficulty assessed by subjective means 
Most studies considered a wide range of general sleep behaviours and difficulties1 
(Allen et al., 1992; Kostanecka-Endress et al., 2003; Modafferi et al., 2016; Wand et al., 1993; 
Mol Debes et al., 2008; Storch et al., 2009), whilst two had more specific parameters (e.g. 
Barabas & Matthews, 1984; Wand et al., 1993). Three studies reported prevalence of DSM-
coded sleep disorders (e.g. insomnia; Ghosh et al., 2014; Saccomani et al., 2005; Tieve et al., 
2001). 
4.2.2 Objective methods 
Sleep was assessed objectively in five of the included studies (36%). One study 
(Hashimoto et al., 1981) included one night polygram, while the remainders used two 
consecutive nights of PSG (Kirov et al., 2007a; Kirov et al., 2007b; Kostanecka-Endress et al., 
2003; Stephens et al., 2007). One study used both objective and subjective methods 
(Kostanecka-Endress et al., 2003).     
 
                                                          
1




4.2.2.2 Types of sleep difficulty assessed by objective means 
All PSG studies considered a wide range of physiological sleep variables including 
analysis of sleep stages and cycles. These studies also reported on sleep efficiency, sleep onset 
latency, degree of movement and microarousals during sleep. Hashimoto et al (1982) 
specifically explored different types of movement, including body movements and twitches 
throughout the night.   
4.3 Results 
Table 2 outlines the main sleep-related findings for each study. 
4.3.1 Overall findings regarding sleep difficulties in TS/CTD 
All 14 included studies found that participants with TS/CTD had more disturbed sleep 
than healthy controls. Estimates of sleep difficulty in TS/CTD-only participants ranged from 17-
80.4% (IQR=21-48), while estimates for controls were 0%-10% (Allen et al., 1992; Mol Debes et 
al., 2008; Saccomani et al., 2005; Storch et al., 2009). Rates of DSM-coded sleep disorders in 
TS/CTD ranged from 9%-65% (Ghosh et al., 2014; Tieve et al., 2001). One study compared rates 
of sleep disorders for a TS-only group and healthy controls, finding 0% in controls (Saccomani 
et al., 2005).  In one study sleep difficulties were reported to significantly impact on daily 
functioning (Ghosh et al., 2014).  
Studies directly comparing clinical samples found that sleep difficulties were most 
common in ADHD-only, followed by TS+ADHD, then TS-only (Allen et al., 1992; Ghosh et al., 
2014). Furthermore, participants with ADHD, regardless of TS-status (i.e. TS+ADHD or ADHD-
only) showed a particular sleep pattern featuring more time in bed, a longer total sleep time, 
higher percentage of REM sleep, more sleep cycles, shorter latency of stages one, two and 
REM sleep and more leg movements during sleep compared to those without ADHD (i.e. TS-
only or healthy controls; Stephens et al., 2013; Kirov et al., 2007b). 
4.3.1.1 Sleep initiation and onset in TS/CTD 
Findings regarding sleep initiation and onset were inconsistent, with studies directly 
measuring initiation finding no significant difference between participants with comorbid 
TS+ADHD and healthy controls, or between TS-only and TS+ADHD (Kirov et al., 2007a; Ghosh et 
al., 2014). However, considering pre-sleep factors more generally, a majority of TS parents 
reported their children had ‘problems getting to sleep’ (Wand et al., 1993), anxiety and fear 
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around sleep, reluctance to go to sleep and need for transitional objects or sleep aids 
(Modafferi et al., 2016).  
4.3.1.2 Sleep maintenance and duration 
Only one study directly commented on sleep maintenance, finding it to be significantly 
more problematic in participants with TS+ADHD compared to TS-only (Ghosh et al., 2014). 
However, compared to other groups, parents of TS-only participants reported a significant 
degree of short restless sleep (Modafferi et al., 2016), wakefulness after sleep onset 
(Kostanecka-Endress et al., 2003), and difficulty staying asleep (Wand et al., 1993). 
Additionally, participants with TS/CTD ± ADHD spent longer in bed and had a longer sleep 
period than controls (Kirov et al., 2007a). 
4.3.1.3 Sleep efficiency 
Two studies directly commented on sleep efficiency, finding it to be reduced in TS/CTD 
compared to healthy controls and ADHD-only participants (Kirov et al., 2007b; Kostanecka-
Endress et al., 2003 
Two studies found that TS participants reported more tiredness on waking and 
daytime sleepiness (Modafferi et al., 2016; Storch et al., 2009), which could also suggest less 
efficient overnight sleep. Additionally, three studies reported significant levels of behaviours 
that could be considered ‘sleep-interfering’, including nightmares (Modafferi et al., 2016; 
Storch et al., 2009), bruxism, snoring (Modafferi et al., 2016), and sleepwalking (Wand et al., 
1993).  
4.3.1.4 Sleep stage analysis 
Studies reporting on sleep stages were inconsistent. Children with TS+ADHD showed a 
significantly higher percentage of REM sleep with a shorter REM latency and increased 
latencies of stages one to three than healthy controls (Kirov et al., 2007a; 2007b). 
Contrastingly, Kostanecka-Endress et al (2003), found no significant difference in REM sleep 
duration or cycle latencies between TS and healthy controls, although TS participants had less 
stage two sleep.  
4.3.1.5 Movements during sleep 
Hashimoto et al (1981) found a different movement pattern in TS participants 
compared to healthy controls. This included more body movements and twitch movements 
during REM sleep. TS participants also reported significantly more hypnic jerks during sleep 
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than controls (Modafferi et al., 2016), and had more motor-related and microarousals during 
sleep (Kirov et al., 2007a; 2007b).  
4.3.1.6 PLMS/SDB 
Four studies reported on prevalence of PLMS and Sleep-Disordered Breathing (SDB). 
Two reported no SDB (Kirov et al., 2007a; Kostanecka-Endress et al., 2003), and infrequent 
PLMS (Kostanecka-Endress et al., 2003). The remaining two studies observed PLMS and SDB 
only in participants with comorbid TS+ADHD (Kirov et al., 2007b; Stephens et al., 2007).  
4.3.2 Additional findings 
Additional findings considered relevant to the current analysis were reported in 10 of 
the 14 included studies (71%). These included links between sleep and participant 
characteristics, tic severity, medications, and comorbid internalising and externalising 
difficulties.  
4.3.2.1 Participant characteristics 
Two studies (14%) considered the impact of participant characteristics on sleep 
(Stephens et al., 2007; Storch et al., 2009), these included age, pubertal status and gender. It 
was found that younger children had more total sleep problems and that pubertal stage was 
linked with total sleep time and percentage of SWS, although the direction of this effect was 
unclear (Storch et al., 2009; Stephens et al., 2007). Storch et al (2009) found that females had 
more sleep difficulties than males. 
4.3.2.2 Tic severity 
Four of the included studies (29%) correlated tic severity and sleep (Kirov et al., 2007b; 
Kostanecka-Endress et al., 2003; Modafferi et al., 2016; Storch et al., 2009). Two studies found 
that increased tic severity linked to reduced sleep efficiency, increased overall latency, 
increased microarousals during REM sleep, hypnagogic hallucinations, sleep talking and 
parasomnias (Kirov et al., 2007b; Modafferi et al., 2016). Two studies (Kostanecka-Endress et 
al., 2003; Storch et al., 2009), observed no association between overall severity and sleep 
parameters, although motor tic severity was negatively associated with total sleep-related 
problems (Storch et al., 2009).  
4.3.2.3 Medications 
Four studies explored relationships between medication-use and sleep (Allen et al., 
1992; Ghosh et al., 2014; Kostanecka-Endress et al., 2003; Modafferi et al., 2016). Two found 
no difference in the physiological or reported sleep parameters of medication-naïve or 
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previously medicated and currently medicated or unmedicated participants (Kostanecka-
Endress et al., 2003; Modafferi et al., 2016). In those finding an association, medication was 
the primary cause of insomnia in 33% and hypersomnia in 7% of one sample (Ghosh et al., 
2014). Another study found antidepressants to be linked with unpleasant dreams and 
stimulants with enuresis (Allen et al., 1992).  
4.3.2.4 Severity of ADHD symptoms in TS 
Of the 14 studies, three (21%) considered relationships between severity and type of 
ADHD symptoms and sleep in TS patients (Kirov et al., 2007a; Kirov et al., 2007b; Stephens et 
al., 2007). In two studies ADHD symptom severity, as determined by Conner’s score and 
degree of attentional problems, was associated with reduced REM sleep latency and increased 
duration of REM sleep (Kirov et al., 2007a; Kirov et al., 2007b). The latter study also found that 
hyperactivity was associated with an increased number of sleep cycles (Kirov et al., 2007b). 
Stephens et al (2007) supported the link between hyperactivity and sleep. They found that 
patients with TS+ADHD and high hyperactivity had more arousals during sleep than those with 
TS+ADHD with low hyperactivity and TS-only, although this was less than participants with 
ADHD-only at both levels of hyperactivity.  
4.3.2.5 Mood and externalising difficulties 
Five studies (36%) considered relationships between mood and sleep (Kirov et al., 
2007b; Kostanecka-Endress et al., 2003; Modafferi et al., 2016; Mol Debes et al., 2008; Storch 
et al., 2009).  Overall, they tended to be related, though one study found no correlation when 
using CBCL score to measure mood (Kostanecka-Endress et al., 2003). In the remaining studies, 
quality of life, internalising symptoms and anxiety were all significantly related to number of 
sleep-related problems (Storch et al., 2009). Furthermore, CBCL score and tic severity when 
combined determined more short motor-related arousals in sleep (Kirov et al., 2007b). In 
another study scores of, or nearing, clinical significance for anxiety or depression were 
associated with abnormal movements pre-sleep (Modafferi et al., 2016). In one study, patients 
with TS and comorbid anxiety had the most sleep problems (Storch et al., 2009), while another 
found that those with multiple comorbidities were most at risk (Mol Debes et al., 2008). 
Another study linked obsessive-compulsive symptoms to problems falling asleep and reduced 
duration (Modafferi et al., 2016). 
In terms of externalising behaviours, one study (7%) considered the relationship 
between sleep and the delinquency, conduct disorder, hyperactivity/immaturity and 
restlessness/disorganised behaviour scales of the CBCL (Achenbach & Rescorla, 2011; Stephens 
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et al., 2007). Delinquency was associated with number of movements during REM sleep, while 
the remaining scales were associated with total number of arousals and SWS arousals.  
4.4 Methodological quality 
Total methodological quality ratings are provided in Table 1. Full scores are presented 
in Appendix 2. Of a maximum of 14, scores ranged from three (Ghosh et al., 2014) to 11 (Kirov 
et al., 2007a; Kirov et al., 2007b; Kostanecka-Endress et al., 2003 & Stephens et al., 2007). The 
average quality rating was 7.6, which is just over 50% of the maximum score. This suggests 
that the available research is of moderate quality, although highly heterogeneous. Items on 
which particularly low ratings were received included not adequately representing the TS 
population (i.e. single recruitment site or only specialist clinics; 12 studies), not justifying or 































Types of sleep 
difficulty 
assessed 
Main sleep-related findings Additional findings or associations 
Allen et al 
(1992) 
 Questionnaire (parents) 
Modified version of Sleep 
Behaviour Questionnaire 
(Simonds & Parraga, 1982) 
Wide range of 
sleep behaviours 
Sleep and behaviour complaints were 
significantly more common in TS and/or 
ADHD than controls. Overall ‘poor sleep’ 






associated with unpleasant dreams; 




 Not stated Somnambulism 
Night terrors 
Enuresis 
TS+Migraine=a significantly greater 
prevalence of disorders of arousal than TS-
only. Highest prevalence=TS+patient 
migraine.  
N/A 
Ghosh et al 
(2014) 
 Questionnaire (young 
person and at least one 
parent/guardian) 
Novel 







Sleep maintenance problems and abnormal 
sleep behaviours were significantly more 
prevalent in TS+ADHD compared to TS-only.  
No significant differences in sleep 
Initiation. 
Both groups=high impact on daily 
functioning secondary to sleep disturbances, 
Medications:  
Hypersomnia secondary to medication  
3%=TS-only 
4%=TS-+ADHD 





but no significant difference between 
groups.  





et al (1981) 
 Sleep polygram (1 night) 
 
Twitch 









6/9 TS Pps=EEG changes during sleep but no 
consistent effect across Pps.  
TS vs HC 
Significantly >BMs & different frequency of 
movements across sleep stages. 
Significantly >TM/min during REM sleep, but 
not during non-REM, or for total sleep time. 
TS Pps within-group 
Significantly >TM=REM vs non-REM. 
N/A 
Kirov et al 
(2007a) 
 
 PSG (2 consecutive 
nights) 
 
Wide range of 
physiological 
sleep variables 
TS+ADHD vs HC 
>time in bed, sleep time, REM sleep %, 
microarousals in light & REM sleep & short 
motor-related arousals 
<REM sleep latency.  
-ve correlation=REM sleep latency & REM %  
No significant differences 
Sleep efficiency, onset, SWS latency, 
duration of wake, light sleep & SWS, % of 
movement & number of microarousals in 
SWS.  
No PLMS or SDB in either group.  
ADHD symptoms: Conner’s scores 
determined changes in REM sleep 
latency & REM duration.  
Kirov et al 
(2007b) 
 PSG (2 consecutive 
nights) 
 
Wide range of 
physiological 
sleep variables 
TS-only & TS+ADHD vs ADHD-only & HC 
<sleep efficiency 
>latency of sleep stages 1, 2 & 3, 
Tic severity: Associated with <sleep 
efficiency, >sleep onset, >SWS latency & 
>microarousals in REM sleep.  
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 microarousals in REM sleep & short motor-
related arousals. 
ADHD-only & TS+ADHD vs TS-only & HC 
>time in bed, sleep period, total sleep time, 
REM % & number of sleep cycles.  
<latency of sleep stage 1, 2 & REM sleep 
Only Pps with ADHD showed evidence of 
PLMS (11%) or SDB (5%). 
Tic severity + psychopathology (CBCL 
score): Determined >short motor-
related arousals. 
Attentional problems: Determined 
>REM duration & <sleep onset latency.  




 Sleep items of CBCL 
(parents) 
 PSG (2 consecutive 
nights) 
 





TS Pps vs HC 
> time in bed, sleep period, wakefulness 
after sleep onset & time awake during night 
<sleep efficiency & sleep stage 2 duration 
No significant differences 
Amount of REM, SWS or stage 1, total sleep 
time, numbers of sleep stage shifts, 
numbers of stages, duration or stage-
latencies of each cycle.  
1 pp=PLMS & 0 Pps=sleep apnea 
Medication use: No difference in sleep 
parameters of medication-naïve and 
previously medicated Pps.  
Tic severity:  No correlations with sleep 
parameters 
Psychopathology: No correlations with 
sleep parameters 
Modafferi 
et al (2016) 
 
 Questionnaire (parents) 
Novel 
Range of sleep 
behaviours & 
difficulties during 
last 6 months 
 
Significant differences on 15 of 45 
questions.  
TS Pps 
>sleep duration <8 hrs, sleep difficulties, 
anxiety/fear around sleep, reluctance to go 
to bed, hypnic jerks, use of sleep aids (e.g. 
fluids, medications, light, tv), transitional 
objects, parasomnias, restless sleep, 
bruxism, snoring and daytime sleepiness. 
Tic severity: >sleep latency, hypnagogic 
hallucinations, sleep talking & 
nightmares.  
Medication use: no difference, 
medicated vs unmedicated TS Pps but 
unmedicated TS Pps vs HC=>sleep 
breathing problems & hypnagogic 
hallucinations. 
Psychopathology: TS Pps with 
borderline/pathological SAFA-A or SAFA-
D=>abnormal movements before sleep.  
TS Pps with borderline/pathological 





et al (2008) 
 Questionnaire (parents) 
Sleep items of CBCL 
‘Sleep 
disturbances’(>6 
on CBCL scale) 
 
17% of Pps=score >6  Psychopathology:  
TS+ADHD+OCD=significantly > likely to 
have sleep disturbances than other 
groups (TS+ADHD, TS/OCD or TS-only). 
Saccomani 
et al (2005) 
 
 Parent report/interview 
 










et al (2013) 
 
 PSG (2 consecutive 
nights) 
 
Wide range of 
physiological 
sleep variables 
TS+ADHD vs other groups 
>PLMS 
TS+ADHD & ADHD-only vs other groups 
>leg movements in sleep 
ADHD-only vs other groups 
>movements during REM sleep, total 
arousals from sleep & arousals from SWS 
Hyperactivity: ADHD-only 
(low- and high-hyperactivity)=>total 
arousals than TS-only, TS+ADHD low-
hyperactivity & controls. TS+ADHD high-
hyperactivity group fell within the 
middle 
Behaviour:  
CBCL delinquency=correlated with 
number of movements during REM 
sleep. 
Conduct disorder scale & measures of 
hyperactivity/immaturity & 
restless/disorganised behaviour 
=correlated with number of total 
arousals & arousals from SWS.  
Pubertal status: Total sleep time and % 
SWS=differed between levels of puberty.  
Storch et al 
(2009) 
 Questionnaire (parents 
and children) 
Items from CBCL (n=6) & 




19.6% of sample=no sleep-related problems 
19.7% of sample=4 or more SRPs 
Most common=nightmares & being 
overtired upon waking 
Gender: Females=>total SRP 
Age: younger children=>total SRP 
Tic severity: Overall severity=not 
associated with SRP, but YGTSS motor 
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combined to make 
composite measure 
scale=-vely correlated with total SRP 
QoL, internalising and externalising and 
anxiety=Significantly related to number 
of total SRP 
Psychopathology: TS+anxiety 
dx=>SRP(‘sleeping less’ & ‘trouble 
sleeping’) 
Teive et al 
(2001) 
 Review of clinic records DSM-IV sleep 
problems 
4 Pps=’sleep problems’ N/A 
Wand et al 
(1993) 
 Questionnaire                         
(Parents/parents+ 
children/children) 
Novel, modelled after the 





Ratings of ‘often’ or ‘sometimes’ 
66.4%=problems getting to sleep 
31.3%=problems staying asleep 
23.5%=sleepwalking 
N/A 
N/A=not applicable; Pps=participants; TS=Tourette syndrome; CTD=chronic tic disorder ADHD=attention deficit hyperactivity disorder; PLMS=periodic limb movements in sleep; SDB=sleep 




This review aimed to summarise existing studies of sleep difficulty in children with 
TS/CTD by focusing on the types and frequencies of sleep problems in this population and 
considering other factors that might affect sleep. Overall, a high prevalence of sleep difficulties 
in this group was identified, with sleep affected by factors such as comorbidity, medication 
use, age and gender. The studies varied in terms of methodology, sample characteristics and 
quality, with current findings based on a small and heterogeneous set of papers. The 
significance of these findings for understanding sleep problems in children with TS/CTD will be 
considered, along with suggestions for future research and potential clinical implications. 
5.1 Types and frequency of sleep difficulties in children with TS/CTD  
The results presented here support previous suggestions that children with TS/CTD 
experience more difficulties sleeping and have a higher prevalence of clinically significant sleep 
problems than typically developing control participants (Ghosh et al., 2014; Saccomani et al., 
2005; Tieve et al., 2001). However, findings were less consistent about the type of difficulties 
experienced. Sleep initiation was not found to be a specific problem (Kirov et al., 2007b; Ghosh 
et al., 2014), although parents reported that before sleep children with TS/CTD felt anxious 
and required reassurance (Modafferi et al., 2016). Furthermore, whilst evidence for objective 
difficulties with sleep maintenance was inconclusive, parents tended to report that children 
with TS/CTD experienced fragmented sleep and sleep-interfering behaviours (e.g. nightmares, 
sleepwalking, bruxism, sleep-talking; Modafferi et al., 2016; Storch et al., 2009). Once asleep, 
PSG studies found that children with TS/CTD appeared to sleep less efficiently than healthy 
controls, although no relationship was reported between sleep efficiency and tic severity 
(Kirov et al., 2007b; Kostanecka-Endress et al., 2003). Nevertheless, increased levels of arousal 
and movement have been reported for some children with TS/CTD compared to healthy 
controls (Hashimoto et al., 1981). Across a number of studies no increased prevalence of 
specific movement disorders was found (e.g. PLMS; Kirov et al., 2007a; Kirov et al., 2007b; 
Kostanecka-Endress et al., 2003; Stephens et al., 2007).  
Thus, although this group clearly do experience a high level of sleep difficulty, the 
current evidence base does not seem to highlight a clear disorder-specific sleep pattern in 
children with TS/CTD. It could be that some of the sleep difficulties, including bruxism, 
movements during sleep and sleep talking echo tics exhibited by children during the daytime. 
It may be that sleep talking and bruxism are, at least in part, expressions of phonic tics while 
others (e.g. sleepwalking) may reflect high physiological arousal. However, to date, there are 
no studies that explicitly explore the relationship between specific daytime tics and 
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movements or arousals exhibited during sleep. This would therefore be a helpful direction for 
future research. 
5.2 Association between sample characteristics and sleep problems 
Age and gender both appeared to impact on sleep problem severity with females and 
younger participants being most at risk (Stephens et al., 2007; Storch et al., 2009). These 
relationships might be partially mediated by a third variable, such as tic severity and/or co-
morbid psychopathology. Although the evidence for a relationship between tic severity and 
sleep was inconclusive overall (Kostanecka-Endress et al., 2003), increased motor tic severity 
was associated with poorer sleep in one study (Storch et al., 2009). Psychopathology also 
appeared related to sleep difficulties with some evidence that children with co-morbid anxiety 
or obsessive-compulsive symptoms might be most at risk (Storch et al., 2009; Modafferi et al., 
2016). However, other studies found that number, rather than type of comorbidity, was 
related to sleep difficulty such that increased difficulties of any type were linked to increased 
sleep problems (Mol Debes et al., 2008).  
In terms of externalising and behavioural difficulties, it appeared that difficulties with 
sleep maintenance, increased sleep stage latencies and REM-sleep changes were more clearly 
linked with ADHD than TS (Kirov et al., 2007a; 2007b). Notably, no significant changes in 
latency or duration of sleep stages or number of sleep cycles were associated with ‘pure’ tic 
disorders (Kostanecka-Endress et al., 2003). However, children with TS/CTD+ADHD showed 
changes to REM sleep latency and duration, and these differences were directly associated 
with severity and type of ADHD symptoms (Kirov et al., 2007a; 2007b). Externalising behaviours 
were positively associated with sleep problems in TS based on scores for ADHD characteristics 
such as hyperactivity and delinquency (Stephens et al., 2007). Furthermore, sleep-related 
movement disorders (PLMS and SDB) did not tend to present in children with TS-only, mostly 
occurring in those with comorbid ADHD (Kirov et al., 2007a; Kirov et al., 2007b; Kostanecka-
Endress et al., 2003; Stephens et al., 2007). This may further support the link between ADHD 
and sleep in the context of TS/CTD. 
Evidence for associations between sleep-related problems and medication-usage were 
unclear from the available evidence. This may partially be due to the lack of disclosure of 
medication status in 50% of included studies (Allen et al., 1992; Ghosh et al., 2014; 
Kostanecka-Endress et al., 2003; Modafferi et al., 2016). A possible hypothesis might be that 
links between sleep and medication-use in TS/CTD are mediated by pre-existing 
psychopathology. For instance, the association between anti-depressants and nightmares 
(Allen et al., 1992) could be due to the high levels of insomnia and nightmares in people with 
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depression (Nakajima, Inoue, Sasai, Okajima, Komada, Nomura et al., 2014) rather than TS/CTD 
specifically.  
5.3 Methodologies of previous studies 
The quality of included studies was mostly moderate, however, scores were highly 
heterogeneous. Only one study followed suggested best practice by using both an objective 
and subjective measure of sleep (Kostanecka-Endress et al., 2003). More studies used 
subjective than objective approaches (64% vs 36%), which may have biased the results through 
factors commonly affecting questionnaire studies (e.g. expectations; Danker-Hopfe, 2011). In 
support of this, differences were identified between studies using different types of measures. 
For instance, while children with TS/CTD did not experience objective difficulties with sleep 
maintenance (Ghosh et al., 2014), subjectively, parents reported that children with TS/CTD had 
significant difficulties staying asleep (Wand et al., 1993).  
5.4 Limitations of previous research 
The reviewed studies had various limitations. There was significant heterogeneity in all 
aspects of the studies discussed here so the present conclusions should be considered 
tentatively. Furthermore, the average quality rating for included studies was moderate, with 
the majority of studies individually scored as moderate or lower. This further impacts on the 
strength of the present conclusions. Many included studies used novel scales to assess sleep 
(sometimes referred to as ‘franken-scales’; Gregory & Sadeh, 2016), which limits 
generalisability and comparability of findings across studies. Additionally, 85% of included 
studies recruited either partially or entirely through specialist clinics, which may mean that 
these participants have more severe TS/CTD than is seen in the general community 
(Robertson, 2000). Recruitment bias may therefore increase the chance and severity of 
difficulties, and thus potentially result in overestimation of rates of sleep disturbances 
compared to the wider population of children with TS/CTD.  Finally, most studies were 
correlational in nature which does not allow consideration of the causality of sleep difficulties 
in TS/CTD. 
5.5 Areas for further study 
The limited evidence meeting criteria for the present review suggests a need for more 
research considering the nature of sleep difficulties in children with TS/CTD. It has been 
suggested that such a complex construct as sleep cannot be adequately assessed using a single 
approach (Gregory & Sadeh, 2016), however, as mentioned previously, very few studies in the 
present review did so. Future studies should therefore aim to use both subjective and 
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objective measures, along with questionnaires with multiple informants where possible. As 
well as giving a more holistic perspective on sleep, studies of this nature would provide 
clinically useful information that could be used to validate measures assessing perceptions of 
sleep by parents and children. Furthermore, only one included study explicitly assessed 
perceptions of the impact of sleep difficulties on everyday functioning (Ghosh et al., 2014). It 
would be helpful for more studies to consider characterising the daytime consequences of 
sleep problems, both objectively and subjectively, as this would further allow clinicians to 
consider functional domains that may be at risk in children with poor sleep. 
Of note, none of the included studies used actigraphy. Five of the 14 studies included 
in this review used PSG, however, this provides a less naturalistic reflection of sleep (Sadeh, 
2015). Children with TS/CTD also moved more during the night than controls (Hashimoto et al., 
1981). Thus, night-time disturbance in children with TS/CTD may be most accurately explored 
using actigraphy, which relies on movement to assess sleep quality.  Furthermore, future 
studies may benefit from including a range of standardised measures, such as the parent-
report Children’s Sleep Habits Questionnaire (CSHQ; Owens, Spirito & McGuinn, 2000), or the 
self-report Dysfunctional Beliefs about Sleep questionnaire (DBAS; Gregory, Cox, Crawford, 
Holland & Haravey, 2009). This would allow more generalizable and comparable conclusions to 
be made between studies and may generate information of greater clinical relevance.  
Recruitment bias was also identified as a problem for many studies included in this 
review, with reliance on tertiary level clinical samples potentially overestimating the nature 
and degree of sleep disturbances. Thus, future studies should aim to explore sleep difficulties 
within more varied cohorts of TS/CTD patients, for instance by also recruiting through 
community clinics or charities. Furthermore, in line with the general male predominance of 
TS/CTD, females were under-represented in all samples. Although clinically-representative, this 
limits the strength of gender comparisons which may be of interest given that one study in the 
current review found females to be more at risk of sleep problems than males (Storch et al., 
2009). Samples including a higher proportion of females would also allow hypotheses 
regarding the influence of hormonal changes on sleep in TS/CTD to be evaluated. Finally, 
although many studies in the present review noted ADHD prevalence, few considered other 
psychopathological comorbidities which are known to contribute to sleep problems in other 
clinical samples (e.g. depression; Devnani & Hedge, 2015). Thus, further evaluation of the 
potentially mediating effects of ADHD symptomatology, psychopathology and tics would also 
be of interest to help determine whether different patterns of sleep disturbance are seen in 
patients with different TS presentations (e.g. pure TS vs TS-plus vs full-blown TS).  
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The studies included in the present review focused on sleep at a single time-point. In 
future it may be interesting to conduct multiple sleep studies with a single cohort thus 
allowing a longitudinal exploration of sleep in TS/CTD. This may allow more causal inferences 
to be made about the impact of various factors on sleep which might inform future treatment 
and management options. In line with this, more researchers should consider specific 
approaches to managing sleep difficulties for children with TS/CTD. As previously outlined, 
interventions to improve sleep are usually pharmacological (Robertson, 2000). In general 
however, medications for sleep management have a mixed evidence base and are usually only 
recommended following failure of behavioural approaches (Kaczor & Skalski, 2016). It would 
therefore be helpful for future research to consider the efficacy of behavioural or 
psychotherapeutic sleep-focused interventions in children with TS/CTD to evaluate whether 
this might be a more efficacious and safe first-line treatment than psychopharmacology, and 
to identify any adaptations necessary for this patient group.  
5.6 Limitations of the current review 
The current findings should be considered within the context of various limitations. It 
is possible that some eligible studies could have been missed through limitations in the search 
strategy. Inclusion criteria was also fairly strict, excluding studies that were not peer-reviewed 
or written in English. This led to exclusion of a number of potentially-relevant abstracts, 
conference proceedings and posters. The heterogeneity of the evidence base and small 
number of included papers also compromises the reliability of conclusions which can be drawn 
here. Furthermore, eight of 63 excluded papers could not be accessed by the researcher. This 
may have biased the included sample towards articles in higher-impact, more recent, freely-
accessible publications. However it should be noted that those excluded may have been 
unpublished due to being of low quality and thus may have had limited relevance for the 
present review. Taken together, these findings emphasise the need for more higher-quality 
studies to be conducted in future. 
5.7 Clinical implications 
Despite limitations of existing evidence and this review, some initial recommendations 
can be made for clinicians working with children with TS/CTD. It was consistently found that 
this cohort experienced significant sleep difficulties suggesting that these should be routinely 
screened for, and sleep hygiene information should be given to prevent or manage sleep 
difficulties early. Children with TS/CTD were said to experience pre-sleep anxiety (Modafferi et 
al., 2016), so may benefit from interventions to support anxiety management (e.g. relaxation), 
alongside sleep-focused advice. This could be especially helpful as children with TS/CTD and 
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comorbid anxiety were at particular risk of sleep problems (Storch et al., 2009). Further 
research around potential non-pharmacological intervention strategies and the daytime 
impact of sleep problems would be helpful in supporting clinicians to more confidently make 
recommendations to families, young people and others involved in their care about promoting 
good-quality sleep.  
5.8 Conclusions 
This review has summarised the current evidence regarding sleep difficulties in 
children with TS/CTD to explore whether any specific disturbances could be considered 
disorder-specific. The available research is limited, highly heterogeneous and mostly of 
moderate quality, but does suggest increased prevalence of sleep difficulties in TS/CTD 
compared to healthy controls. Some differences appear to be present between this and other 
clinical groups (e.g. ADHD), which may be indicative of different aetiology of sleep disturbance 
between conditions. However, at present, it does not appear that enough high-quality 
evidence exists to allow firm conclusions to be drawn regarding the disorder-specificity of 
sleep problems in TS/CTD. Limitations of the current review and evidence base, as well as 
suggestions for future research and clinical implications of these preliminary findings have 
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Appendix 1: Quality Assessment Tool 
Reference:            Date of ax: 
Criteria Scoring System Score 
1. Are the aims and 







2. Is the sample 
representative of the TS 
population? 
 
Multiple recruitment sites/includes clinic 
and/or community participants 
Single site/specialist-clinic only 
1 
0 
3. Did the sample include a 
Typically Developing comparison 
group? 
Typically developing control group 





4. Is there an adequate 
sample size? 
 
Power analysis conducted and reported or 
sample size discussed 

























8. Validated measure of sleep 
used? 






9. Sample adequately 
characterised in terms of mean IQ, 
age and gender distribution? 
All three reported 
Only two reported 




10. If >1 group, were they 
matched for age, IQ and gender? 
All three 
Only two 











12. P values 













Reference: Allen et al (1992)            Date of ax: 10/12/216 
Criteria Scoring System Score 
1. Are the aims and hypotheses of the 






2. Is the sample representative of the 
TS population? 
 
Multiple recruitment sites/includes clinic 
and/or community participants 
Single site/specialist-clinic only 
1 
0 
3. Did the sample include a Typically 
Developing comparison group? 
Typically developing control group 





4. Is there an adequate sample size? 
 
Power analysis conducted and reported or 
sample size discussed 




























9. Sample adequately characterised in 
terms of mean IQ, age and gender 
distribution? 
All three reported 
Only two reported 




10. If >1 group, were they matched for 
age, IQ and gender? 
All three 
Only two 




11. Comorbid neurodevelopmental 
and/or psychiatric conditions 
















Reference: Barabas & Matthews            Date of ax: 10/12/2016 
Criteria Scoring System Score 
1. Are the aims and hypotheses of the 






2. Is the sample representative of the 
TS population? 
 
Multiple recruitment sites/includes clinic 
and/or community participants 




3. Did the sample include a Typically 
Developing comparison group? 
Typically developing control group 





4. Is there an adequate sample size? 
 
Power analysis conducted and reported or 
sample size discussed 




























9. Sample adequately characterised in 
terms of mean IQ, age and gender 
distribution? 
All three reported 
Only two reported 




10. If >1 group, were they matched for 
age, IQ and gender? 
All three 
Only two 




11. Comorbid neurodevelopmental 
and/or psychiatric conditions 











                                                                                                                                                                 










Reference: Ghosh et al (2014)            Date of ax: 10/12/2016 
Criteria Scoring System Score 
1. Are the aims and hypotheses of the 






2. Is the sample representative of the 
TS population? 
 
Multiple recruitment sites/includes clinic 
and/or community participants 




3. Did the sample include a Typically 
Developing comparison group? 
Typically developing control group 





4. Is there an adequate sample size? 
 
Power analysis conducted and reported or 
sample size discussed 




























9. Sample adequately characterised in 
terms of mean IQ, age and gender 
distribution? 
All three reported 
Only two reported 




10. If >1 group, were they matched for 
age, IQ and gender? 
All three 
Only two 




11. Comorbid neurodevelopmental 
and/or psychiatric conditions 





















Reference: Hashimoto et al (1980)            Date of ax: 10/12/2016 
Criteria Scoring System Score 
1. Are the aims and hypotheses of the 






2. Is the sample representative of the 
TS population? 
 
Multiple recruitment sites/includes clinic 
and/or community participants 




3. Did the sample include a Typically 
Developing comparison group? 
Typically developing control group 





4. Is there an adequate sample size? 
 
Power analysis conducted and reported or 
sample size discussed 




























9. Sample adequately characterised in 
terms of mean IQ, age and gender 
distribution? 
All three reported 
Only two reported 




10. If >1 group, were they matched for 
age, IQ and gender? 
All three 
Only two 




11. Comorbid neurodevelopmental 
and/or psychiatric conditions 











                                                                                                             










Reference: Kirov et al (2007a)            Date of ax: 10/12/2016 
Criteria Scoring System Score 
1. Are the aims and hypotheses of the 






2. Is the sample representative of the 
TS population? 
 
Multiple recruitment sites/includes clinic 
and/or community participants 




3. Did the sample include a Typically 
Developing comparison group? 
Typically developing control group 





4. Is there an adequate sample size? 
 
Power analysis conducted and reported or 
sample size discussed 




























9. Sample adequately characterised in 
terms of mean IQ, age and gender 
distribution? 
All three reported 
Only two reported 




10. If >1 group, were they matched for 
age, IQ and gender? 
All three 
Only two 




11. Comorbid neurodevelopmental 
and/or psychiatric conditions 





















Reference: Kirov et al (2007b)            Date of ax: 10/12/2016 
Criteria Scoring System Score 
1. Are the aims and hypotheses of the 






2. Is the sample representative of the 
TS population? 
 
Multiple recruitment sites/includes clinic 
and/or community participants 




3. Did the sample include a Typically 
Developing comparison group? 
Typically developing control group 





4. Is there an adequate sample size? 
 
Power analysis conducted and reported or 
sample size discussed 


























9. Sample adequately characterised in 
terms of mean IQ, age and gender 
distribution? 
All three reported 
Only two reported 




10. If >1 group, were they matched for 
age, IQ and gender? 
All three 
Only two 




11. Comorbid neurodevelopmental 
and/or psychiatric conditions 





















Reference: Kostanecka-Endress et al (2003)            Date of ax: 10/12/2016 
Criteria Scoring System Score 
1. Are the aims and hypotheses of the 






2. Is the sample representative of the 
TS population? 
 
Multiple recruitment sites/includes clinic 
and/or community participants 




3. Did the sample include a Typically 
Developing comparison group? 
Typically developing control group 





4. Is there an adequate sample size? 
 
Power analysis conducted and reported or 
sample size discussed 




























9. Sample adequately characterised in 
terms of mean IQ, age and gender 
distribution? 
All three reported 
Only two reported 




10. If >1 group, were they matched for 
age, IQ and gender? 
All three 
Only two 




11. Comorbid neurodevelopmental 
and/or psychiatric conditions 





















Reference: Modafferi et al (2016)            Date of ax: 10/12/2016 
Criteria Scoring System Score 
1. Are the aims and hypotheses of the 






2. Is the sample representative of the 
TS population? 
 
Multiple recruitment sites/includes clinic 
and/or community participants 




3. Did the sample include a Typically 
Developing comparison group? 
Typically developing control group 





4. Is there an adequate sample size? 
 
Power analysis conducted and reported or 
sample size discussed 


























9. Sample adequately characterised in 
terms of mean IQ, age and gender 
distribution? 
All three reported 
Only two reported 




10. If >1 group, were they matched for 
age, IQ and gender? 
All three 
Only two 




11. Comorbid neurodevelopmental 
and/or psychiatric conditions 





















Reference: Mol Debes et al (2008)            Date of ax: 10/12/2016 
Criteria Scoring System Score 
1. Are the aims and hypotheses of the 






2. Is the sample representative of the 
TS population? 
 
Multiple recruitment sites/includes clinic 
and/or community participants 




3. Did the sample include a Typically 
Developing comparison group? 
Typically developing control group 





4. Is there an adequate sample size? 
 
Power analysis conducted and reported or 
sample size discussed 




























9. Sample adequately characterised in 
terms of mean IQ, age and gender 
distribution? 
All three reported 
Only two reported 




10. If >1 group, were they matched for 
age, IQ and gender? 
All three 
Only two 




11. Comorbid neurodevelopmental 
and/or psychiatric conditions 





















Reference: Saccomani et al (2005)            Date of ax: 10/12/2016 
Criteria Scoring System Score 
1. Are the aims and hypotheses of the 






2. Is the sample representative of the 
TS population? 
 
Multiple recruitment sites/includes clinic 
and/or community participants 




3. Did the sample include a Typically 
Developing comparison group? 
Typically developing control group 





4. Is there an adequate sample size? 
 
Power analysis conducted and reported or 
sample size discussed 




























9. Sample adequately characterised in 
terms of mean IQ, age and gender 
distribution? 
All three reported 
Only two reported 




10. If >1 group, were they matched for 
age, IQ and gender? 
All three 
Only two 




11. Comorbid neurodevelopmental 
and/or psychiatric conditions 





















Reference: Stephens et al (2013)            Date of ax: 10/12/2016 
Criteria Scoring System Score 
1. Are the aims and hypotheses of the 






2. Is the sample representative of the 
TS population? 
 
Multiple recruitment sites/includes clinic 
and/or community participants 




3. Did the sample include a Typically 
Developing comparison group? 
Typically developing control group 





4. Is there an adequate sample size? 
 
Power analysis conducted and reported or 
sample size discussed 




























9. Sample adequately characterised in 
terms of mean IQ, age and gender 
distribution? 
All three reported 
Only two reported 




10. If >1 group, were they matched for 
age, IQ and gender? 
All three 
Only two 




11. Comorbid neurodevelopmental 
and/or psychiatric conditions 





















Reference: Storch et al (2009)            Date of ax: 10/12/2016 
Criteria Scoring System Score 
1. Are the aims and hypotheses of the 






2. Is the sample representative of the 
TS population? 
 
Multiple recruitment sites/includes clinic 
and/or community participants 




3. Did the sample include a Typically 
Developing comparison group? 
Typically developing control group 





4. Is there an adequate sample size? 
 
Power analysis conducted and reported or 
sample size discussed 




























9. Sample adequately characterised in 
terms of mean IQ, age and gender 
distribution? 
All three reported 
Only two reported 




10. If >1 group, were they matched for 
age, IQ and gender? 
All three 
Only two 




11. Comorbid neurodevelopmental 
and/or psychiatric conditions 





















Reference: Tieve et al (2001)            Date of ax: 10/12/2016 
Criteria Scoring System Score 
1. Are the aims and hypotheses of the 






2. Is the sample representative of the 
TS population? 
 
Multiple recruitment sites/includes clinic 
and/or community participants 




3. Did the sample include a Typically 
Developing comparison group? 
Typically developing control group 





4. Is there an adequate sample size? 
 
Power analysis conducted and reported or 
sample size discussed 




























9. Sample adequately characterised in 
terms of mean IQ, age and gender 
distribution? 
All three reported 
Only two reported 




10. If >1 group, were they matched for 
age, IQ and gender? 
All three 
Only two 




11. Comorbid neurodevelopmental 
and/or psychiatric conditions 






















Reference: Wand et al (1993)            Date of ax: 10/12/2016 
Criteria Scoring System Score 
1. Are the aims and hypotheses of the 






2. Is the sample representative of the 
TS population? 
 
Multiple recruitment sites/includes clinic 
and/or community participants 




3. Did the sample include a Typically 
Developing comparison group? 
Typically developing control group 





4. Is there an adequate sample size? 
 
Power analysis conducted and reported or 
sample size discussed 




























9. Sample adequately characterised in 
terms of mean IQ, age and gender 
distribution? 
All three reported 
Only two reported 




10. If >1 group, were they matched for 
age, IQ and gender? 
All three 
Only two 




11. Comorbid neurodevelopmental 
and/or psychiatric conditions 
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73 
Objectives: Sleep difficulties are often assumed to be common in children with tic 
disorders such as Tourette syndrome (TS) and may be related to neurobehavioural and 
psychopathological outcomes in this group (Modafferi, Stornelli, Chiarotti, Cardona, & Bruni, 
2016; Kirov, Brand, Banaschewski & Rothenberger, 2017). However, existing research into 
associations between these functional domains in this clinical group is limited and highly 
heterogeneous. This study will compare naturalistic sleep patterns and possible factors 
associated with disturbed sleep in a group of children with tic disorders and a matched 
typically developing control group. It will also consider relationships between sleep, 
psychopathology and learning in these groups and explore the process of overnight 
information consolidation as a potential mechanism for altered sleep-dependent learning. 
Methods: Sleep was assessed in a sample of 32 young adolescent males with tic 
disorders (n=16) and age-, gender- and IQ-matched typically developing controls (n=16) using 
actigraphy. Participants and their parents completed a set of clinical questionnaires to 
measure psychopathology and children were administered a comprehensive 
neuropsychological battery to assess cognitive functioning. Overnight information 
consolidation was assessed using a novel set of computerised tasks which were completed by 
participants before and after a single night of sleep. 
Results: Sleep was highly variable in the clinical group but overall was not significantly 
different between groups. For children with TS, longer onset latency was associated with 
significantly more symptoms of depression and panic disorder and poorer learning 
performance on a verbal memory task than controls. Comparatively, no significant associations 
emerged between sleep, psychopathology and overnight learning in the control group. Trends 
in the data are suggestive of different overnight learning profiles and different associations 
between consolidation and underlying cognitive skills between groups. 
Conclusions: Differences in relationships with psychopathology, patterns of learning 
and associations with neurocognitive abilities suggest the possibility of different mechanisms 
underlying associations between sleep and daytime functioning between these groups. The 
importance of these findings in supporting systematic screening of sleep difficulties alongside 






2.1 Sleep Overview 
Sleep is an active, restorative state said to be “of the brain, by the brain and for the 
brain” (p. 487; Anderson, 2015). Sleep quality and quantity is determined by interacting 
physiological, chronobiological and neurological processes (Beebe, 2012). Regulation of sleep 
is determined by the balance between the wakefulness-related circadian drive (known as 
‘process C’) and the sleep-facilitating homeostatic drive (‘Process S’; Sinha, Jhaveri & Banga, 
2015). Neurologically sleep-wake regulation begins with arousal-promoting glutamatergic, 
cholinergic, noradrenergic, dopaminergic and histaminergic projections from the brainstem 
and hypothalamus which ascend either directly or via the thalamus into the cortex. 
Concomitantly gamma-aminobutyric acid (GABA)-ergic hypothalamic projections are 
deactivated which has an excitatory effect on the sympathetic nervous system. This dynamic 
balance of systems is stabilised by hypothalamic orexin/hypocretin-producing neurons (Beebe, 
2012). During the initial stages of sleep (N1 and N2) hypothalamic GABA pathways become 
more active, inhibiting the arousal-related projections as parasympathetic activation slows 
heart rate, blood pressure and respiration. As the third sleep stage (slow wave sleep (SWS)) 
begins, thalamo-cortical-thalamic circuits organise slow, synchronised, rhythmic firing of large 
neuronal groups. The fourth sleep stage (rapid eye movement (REM) sleep) follows activation 
of cholinergic systems with simultaneous suppression of aminergic and histaminergic 
pathways. This results in heightened thalamic, limbic and posterior cortical activity, continued 
deactivation of anterior cortical areas and inhibition of motor signals (Beebe, 2012). These 
stages occur in repeated cycles during a sleep period. Sleep is therefore an extremely 
vulnerable and complex process associated with multiple interacting systems, changes to any 
of which can cause sleep disturbance.  
Sleep patterns change throughout development with a significant shift at the 
transition from childhood to adolescence; this is linked to hormonal and central nervous 
system (CNS) development, lifestyle factors (e.g. electronic media usage) and a tendency 
towards ‘eveningness’ (Barclay & Gregory, 2014; MacLean, Fitzgerald & Waters, 2015; de 
Bruin, van Run, Staaks & Meijer, 2017). At this developmental stage, inconsistencies also occur 
across school terms and holidays with the latter being characterised by increased autonomy 
and often subsequently less routine sleep (Danker-Hopfe, 2011). Sleep maturation is highly 
inter- and intra-individually variable and, due to its reliance on CNS development, occurs 
differently across clinical and healthy populations (Meltzer, 2017). 
 
2.1.1 Functions of sleep 
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Despite being a time of relative physical inactivity, during sleep the brain actively 
processes and stores information (Tesler, Gerstenberg & Huber, 2013). Key functions of sleep 
are to support emotional regulation and facilitate learning (Vriend, Davidson, Rusak & Corkum, 
2015). Insufficient or disturbed sleep can therefore significantly affect social, academic and 
neurobehavioural functioning (Ashworth, Hill, Karmiloff-Smith & Dimitriou, 2014).  
2.1.2 Sleep and emotional functioning 
A key role of sleep is to support emotional processing and regulation. In line with this, 
sleep disturbance is a central feature of many psychological disorders including depression 
(Chorney, Detweiler, Morris & Kuhn, 2008), anxiety (Hansen, Skirbekk, Oerbeck, Wentzel-
Larsen & Kristensen, 2014) and obsessive compulsive disorder (OCD; Paterson, Reynolds, 
Ferguson & Dawson, 2013). The relationship between sleep and psychopathology varies 
between disorders but is generally assumed to be bidirectional and moderated by 
neuropathological and behavioural mechanisms (Basseti, Ferini-Strambi, Brown, Adamantidis, 
Benedetti, Bruni et al., 2015). Neurologically, shorter sleep duration contributes to enhanced 
reactivity of regions involved in emotional processing, including the amygdala and insula, along 
with weakened connections to regulatory areas of the prefrontal cortex (PFC; Reidy, Hamann, 
Inman, Johnson & Brennan, 2016). Furthermore, changes in the functioning of 
neurotransmitters dopamine (DA) and serotonin (5-HT) are implicated in a range of 
neurodevelopmental and psychiatric conditions and also affect the circadian system. This 
reinforces the intimate neurobiological link between sleep and emotional functioning (Harvey, 
Murray, Chandler & Soehner, 2011).   
Children with psychiatric and developmental conditions also exhibit disorder-specific 
behaviours that impact on sleep duration and quality (Ramtekkar & Ivanenko, 2015). For 
instance, children with autism spectrum disorder (ASD) often show delayed sleep onset due to 
ritualistic tendencies, arousal dysregulation and impaired self-soothing (Beebe, 2012). 
Attention deficit hyperactivity disorder (ADHD) is also characterised by sleep onset difficulties 
but these typically present as bedtime resistance linked to restlessness and oppositionality 
(Cortese, Faraone, Konofal & Lecendreux, 2009). Sleep difficulties can be further inadvertently 
reinforced by parental accommodations (e.g. co-sleeping; Thompson-Hollands, Kerns, Pincus & 
Comer, 2014) and systemic factors (e.g. family conflict) which are often elevated in families 
where children have disabilities (El-Sheikh, Kelly, Bagley & Wetter, 2012). 
 
 
2.1.3 Sleep and learning 
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As outlined, another key task for the sleeping brain is to consolidate information; that 
is to facilitate learning through strengthening memory traces acquired during waking hours 
(Astill, Van der Heijden, Van IJzendoorn & Van Someren, 2012; Born & Wagner, 2009). In 
typically developing children consolidation occurs during SWS and REM sleep, with the former 
supporting episodic declarative memories and the latter being important for emotional 
consolidation and regulation (Walker, 2009; Weisner, Pulst, Krause, Elsner, Baving, Pedersen et 
al., 2015). The association between sleep and learning in non-clinical children is affected by a 
range of individual (e.g. age, socio-economic status, ethnicity), task-related (e.g. complexity, 
salience) and situational factors (e.g. motivation, arousal level; Sadeh, Gruber & Raviv, 2002; 
McMakin & Alfano, 2015; Philbrook, Hinnant, Elmore-Staton, Buckhalt & El-Sheikh, 2017). 
Despite various theories of consolidation being proposed (e.g. ‘active systems consolidation’ 
Born & Wilhelm, 2012; ‘synaptic-homeostasis’; Tononi & Cirelli, 2003) the mechanisms 
underlying this process remain insufficiently understood.  
Associations between sleep duration and volumes of neural regions such as the 
hippocampus reinforce the role of sleep in learning (Taki, Hashizume, Thyreau, Sassa, 
Takeuchi, Wu et al., 2012). The hippocampus is often activated alongside the amygdala during 
sleep (Diekelman, Wilhelm & Born, 2009). This supports the notion that emotional memories 
are preferentially consolidated over those which are neutral. Regions of the PFC are also 
implicated in consolidation through ‘marking’ memories for recall and facilitating encoding, 
which relies on dopaminergic regulation of neural plasticity (Berry, Cervantes-Sandoval, 
Chakroborty & Davis, 2015). Correspondingly, consolidation appears to function differently in 
individuals with altered DA transmission and PFC development (e.g. ADHD; Prehn-Kristensen, 
Göder, Fischer, Wilhelm, Seeck-Hirschner, Adenhoff & Baving, 2011). For instance, initial 
studies have found that compared to typically developing children, in ADHD, salient (i.e. 
emotionally valenced or rewarding) information tends not to be preferentially consolidated 
over neutral stimuli during sleep (Wiesner, Molzow, Prehn-Kristensen & Baving, 2017; Prehn-
Kristensen, Munz, Molsow, Wilhelm, Weisner & Baving, 2013). Furthermore, REM sleep 
duration has been found to be associated differently with measures of cognitive and emotional 
functioning in children with developmental disorders and typically developing peers (e.g. 
ADHD, Tourette syndrome (TS); Kirov et al., 2017). As REM sleep is known to support 
consolidation (Weisner et al., 2015), this may occur through changes in this underlying 
mechanism. However, despite initial studies into this process in ADHD, to the author’s 
knowledge overnight consolidation has not yet been explicitly explored in children with TS. 
Thus, sleep disturbances have wide-ranging effects on everyday functioning in typically 
developing children and may exacerbate or add to functional disability in clinical populations. 
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Understanding and managing sleep problems is therefore being increasingly recognised as a 
crucial factor in enhancing children’s wellbeing and supporting optimal development (Harvey 
et al., 2011; Maski & Kothare, 2013). 
2.1.4 Sleep assessment  
The complex neurobehavioural nature of sleep makes it challenging to accurately 
assess (Gregory & Sadeh, 2012). Questionnaires are a time- and cost-effective way to gather 
information about perceptions of sleep from multiple respondents. They are useful for 
identifying sleep-related concerns and understanding bedtime habits (Mouthon & Huber, 
2015). However their inherently subjective nature makes them unsuitable for diagnosis of 
sleep disorders, or characterising sleep architecture (Danke-Hopfer, 2011). For this, objective 
techniques, such as the ‘gold standard’, polysomnography (PSG) should be used. PSG involves 
laboratory monitoring, usually over two nights, and generates extremely detailed information 
about sleep physiology. However, due to the requirement to sleep in a laboratory during 
monitoring, PSG is not especially representative of natural sleep patterns (Sadeh, 2015). An 
alternative objective approach is actigraphy. This uses an accelerometer to assess movement 
and light levels from which habitual sleep-wake patterns can be determined. Actigraphic 
recordings are typically collected for days or weeks and devices can be used within 
participants’ own homes (Mouthon & Huber, 2015). Although not precise enough to allow 
diagnosis of sleep disorders or reliably assess sleep quality, actigraphy is useful for identifying 
sleep quantity and general disturbance in children (Galland, Meredith-Jones, Terrill & Taylor, 
2014; Danker-Hopfer, 2011).  Accuracy is enhanced by using sleep logs to validate actigraphy 
data and determine artefacts (e.g. device removal; Mouthon & Huber, 2015). Although it is 
clearly important to assess perceptions of sleep (Honomichl, Goodlin-Jones, Burnham, Gaylor 
& Anders, 2002), subjective and objective measures tend to correlate weakly and the latter is 
generally considered more accurate (Markovich, Gendron & Corkum, 2015; Kushnir & Sadeh, 
2013).   
2.2 Tourette syndrome 
Gilles de la Tourette syndrome (TS) is a complex neuropsychiatric condition 
characterised by the presence of multiple motor tics and at least one phonic tic that have been 
present for at least one year, begin before 18 years of age and are not caused by medications 
or health conditions (DSM-V; American Psychiatric Association, 2013). Tics are brief, sudden 
movements or sounds sometimes preceded by a premonitory ‘urge’ (Brandt, Beck, Sajin, 
Baaske, Bäumer, Beste et al., 2016). They are suggestible, suppressible and vary in frequency 
(Kumar, Trescher & Byler, 2016). Tics usually first appear in childhood and peak in severity 
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around 10-12 years. They often improve during adolescence and can disappear by adulthood 
(Bloch & Leckman, 2009; Freeman, Fast, Burd, Kerbeshian, Robertson, & Sandor, 2000). Tics 
can be simple or complex. ‘Simple’ tics involve single muscles or sounds (e.g. eye-blinking, 
coughing) while those considered ‘complex’ include multiple muscles or body parts, speaking 
phrases or strings of sounds. Whereas simple tics are clearly purposeless, complex tics may 
appear purposeful (e.g. grooming actions) and can present as copying other people’s 
movements (‘echopraxia’), copying speech (‘echolalia’) or making obscene gestures or 
comments (‘copraphenomena’). Overall prevalence estimates for TS in childhood are around 
0.77% and it is approximately four times more common in males than females (Knight, 
Steeves, Day, Lowerison, Jette & Pringesheim, 2012; Freeman et al., 2000).  
TS is approximately 60% heritable (Matthews & Stern, 2016) and although few single 
risk genes have been identified (Richer & Fernandez, 2015), those related to DA transmission 
are often altered (Du, Chiu, Lee, Wu, Yang, Hsu et al., 2010). DA is not the only 
neurotransmitter implicated in TS pathophysiology, with evidence also supporting roles for 
noradrenaline, glutamate, 5-HT, histamines and GABA (Nordstrom, Bittner, McGrath, Parks & 
Burton, 2015; Leckman, Bloch, Smith, Larabi & Hampson, 2010). However DA has a substantial 
evidence base due to the effectiveness of its antagonists in managing TS symptoms (Paschou, 
Fernandez, Sharp, Heiman & Hoekstra, 2013; Shprecher, Schrock & Himle, 2014). Although the 
nature of its role in TS is debated (Buse, Schoenefeld, Münchau & Roessner, 2013) patients 
show delayed maturation of the DA-mediated PFC as well as alterations across regions linking 
frontal to subcortical areas (Yaniv, Benaroya-Milshtein, Steinberg, Ruhrrman, Apter & Lavidor, 
2017; Worbe, Malherbe, Hartmann, Pelegrini-Isaac, Messe, Vidailhet et al., 2012). Neurological 
changes are thought to occur across interacting cortico-striatal-thalamo-cortical (CSTC) circuits 
(Robertson, Eapen, Singer, Martino, Scharf, Paschou et al., 2017). These include a premotor-
putamen circuit associated with habitual-behavioural functions, a goal-directed ventromedial 
PFC-caudate nucleus circuit and a limbic circuit, which collaboratively implicate a network of 
regions associated with inhibition, habit formation and reward in TS pathophysiology (Mink, 
2001). These structural differences are accompanied by aberrant patterns of neural 
functioning, with a well-supported hypothesis attributing tics to hypoactivity in striatopallidal 
neurons which impairs inhibition of GABA-ergic basal ganglia-generated motor patterns 
(Felling & Singer, 2011). This inhibitory impairment becomes habitual following reinforcing DA-
release due to caudate and PFC hyperactivity (Leckman et al., 2010). The link between tics and 
inhibitory control is further supported by neurocognitive findings of impaired verbal and motor 
inhibition in TS (Matthews & Stern, 2016). 
79 
Although impaired inhibition of overactive motor networks appears central to TS 
pathophysiology, this does not explain tic fluctuations or failures in suppression during times 
of stress or stimulation (McGuire, 2016; Jackson, Draper, Dyke, Pépés & Jackson, 2015; 
Ruhrman, Gev, Benaroya-Milshtein, Fennig, Krispin, Apter & Steinberg, 2017). One explanation 
of this links tic fluctuations to homeostatic changes which are reflected in TS patients’ 
heightened stress-related cortisol release and hypothalamic-pituitary-adrenocortical (HPA) axis 
hyperactivity (Godar & Bortolato, 2016; Buse, Kirschbaum, Leckman, Münchau & Roessner, 
2014; Corbett, Mendoza, Baym, Bunge & Levine, 2008).  
2.2.1 TS and comorbidity 
Overall, therefore, TS is a highly complex psychophysiological syndrome (Lavoie, 
Leclerc & O’Connor, 2013), reflected in its position “at the border between neurology and 
psychiatry” (p 20; Cavanna, Servo, Monaco & Robertson, 2009). Attempts to make TS more 
comprehensible have led clinicians and researchers to subtype the condition. A common 
distinction is between ‘Pure TS’ (tics only), ‘TS plus’ (TS accompanied by echo- 
and copraphenomena) and ‘Full Blown TS’ (‘TS plus’ with comorbid neurodevelopmental 
and/or psychiatric difficulties; Robertson & Baron-Cohen, 1998). Pure TS is considered ‘the 
exception, rather than the rule’ (Leckman, Bloch, Scahill & King, 2006) with common 
comorbidities including ADHD, OCD and depression (Ferreira, Pio-Abreu & Januario, 2014; 
Cavanna et al., 2009). Comorbid conditions often prompt TS patients to seek medical attention 
(Robertson, 2000) and lead to reduced quality of life (QoL) than is reported by those without 
comorbidities (Eapen, Snedden, Črnčec, Pick & Sachdev, 2016; Hesapçıoğlu, Tural & Kandil, 
2014).  
The relationship between TS and comorbidity is complex and, like tics themselves, 
likely to be multifactorial. Neurochemical and neuroanatomical changes, such as DA and CSTC 
abnormalities, are shared across TS and other conditions (e.g. depression; Peters, Dunlop & 
Downar, 2016; Grace, 2017). However the experience of having tics also directly impacts on 
wellbeing, as ‘pure TS’ patients experience emotional and social difficulties and tic severity is 
linked to low mood and suicidal thoughts (Zinner, Conelea, Glew, Woods & Budman, 2014; 
Storch, Hanks, Mink, McGuire, Adams, Augustine, Vierhile, Thatcher et al., 2015).  Growing 
awareness of the significant psychosocial burden associated with TS has stimulated research 
specifically into ‘plus’ forms of the condition, as well as factors influencing wellbeing and 
health related-QoL (HR-QoL) across disorder subtypes (Sprecher et al., 2014). It is hoped that 
this will facilitate development of a fuller understanding of TS and inform targeted therapeutic 
interventions to improve functional outcomes for patients and families (O’Hare, Helmes, 
Reece, Eapen & McBain, 2016). 
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2.2.2 Sleep in TS 
Since the initial conceptualisation of TS, patients’ sleep has been of clinical interest 
(Konofal, Karroum, Montplaisir, Derenne & Arnulf, 2009). Despite suggestions that sleep is not 
always disturbed in ‘pure TS’ (Freeman et al., 2000) and that tics are ameliorated during sleep 
(Hashemiyoon, Kuhn & Visser-Vanderwalle, 2017), clinically significant sleep disorders have 
been reported in up to 65% of TS samples (Ghosh, Rajan, Das, Datta, Rothner & Erenberg, 
2014). Studies relying on parent-report have found significant pre-sleep anxiety (Modaferri et 
al., 2016) as well as fragmented sleep and frequent sleep-interfering behaviours (e.g. bruxism, 
sleepwalking) in this group (Modafferi et al., 2016; Storch, Milsom, Lack, Pence, Geffken, Jacob 
et al., 2009). PSG studies have typically found children with TS to sleep less efficiently and 
move more overnight than healthy controls (Kirov, Kinkelbur, Banaschewski, & Rothenberger, 
2007; Kostanecka-Endress, Banaschewski, Kinkelbur, Wullner, Lichtblau, Cohrs et al., 2003; 
Hashimoto, Endo, Fukuda, Hiura, Kawano, Suzue et al., 1981).  
Although some studies have concluded that sleep difficulties in TS are due to comorbid 
conditions (e.g. ADHD; Allen, Singer, Brown & Salam, 1992) or additional factors (e.g. 
medications, Ayalon, Hermesh & Dagan, 2002; Cavanna, Selvini, Termine, Luoni, Eddy & 
Rickards, 2012), others have suggested that sleep disturbance is a central aspect of TS (Kirov et 
al., 2007). In support of this, some studies have linked tic severity to sleep disturbance (Kirov 
et al., 2007) and others have observed sleep improvements following pharmacological 
treatment of tics (Arana-Lechuga, Sanchez-Escandon, Santiago-Trevino, Castillo-Montoya, 
Teran-Perez & Velazquez-Moctezuma, 2008). TS patients can display tic-like movements and 
other motoric arousals during sleep and this may reflect overnight consolidation of tic-related 
motor programs (Kirov, Becker & Rothenberger, 2014; Kirov et al., 2007; Cohrs, Rasch, 
Altmeyer, Kinkelbur, Kostanecka, Rothenberger et al., 2001). Presence of overnight 
movements could also implicate physiological hyper-arousal in the aetiology of both tics and 
sleep disturbance (Modafferi et al., 2016). Furthermore, the importance of neural regions 
across the CSTC network and reliance on physiological homeostasis for sleep, both of which 
are impaired in TS, could contribute to disturbed sleep in patients. Attempts have therefore 
been made to characterise and understand sleep difficulties in TS. However the existing 
evidence base is highly inconsistent and limited, being based primarily on small, clinically-
recruited samples (Hibberd et al., 2017). Furthermore to the author’s knowledge all previous 
studies have assessed sleep using PSG or questionnaires with none using the naturalistic 
objective approach of actigraphy.  
Exploration into the functional impact of poor sleep in TS is also only just beginning. 
Initial studies have found associations between sleep disturbances and internalising and 
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externalising difficulties in patients (Storch et al., 2009; Freeman et al., 2000). From these 
initial findings a reciprocal relationship has been proposed between sleep, tics and daytime 
functioning. Within this relationship, tics could contribute to sleep difficulties which would 
negatively affect psychosocial and neurobehavioural functioning, in turn increasing tic 
occurrence and further impairing functioning (Kirov et al., 2014). Partial support for this is 
provided by a recent study of children with TS which confirmed a positive association between 
sleep disturbance and psychopathology (Modaferri et al., 2016). These authors also extended 
the previous proposal by finding links between particular psychological symptoms and sleep 
profiles in this group. Specifically, anxiety was linked to sleep-related movement while both 
depression and OCD were associated with sleep initiation difficulties (Modaferri et al., 2016). 
However, this study relied on parent-report of sleep, which as previously outlined is not the 
most accurate method of assessment (Kushnir & Sadeh, 2013). Furthermore, the authors did 
not consider the impact of reported sleep problems on areas of functioning other than 
psychopathology. Considering recent findings of opposing associations between REM sleep 
duration and neurobehavioural functioning in children with TS/ADHD and healthy controls 
(Kirov et al., 2017) as well as suggestions of altered processes of consolidation in ADHD 
(Weisner et al., 2017), it would be helpful to directly explore both consolidation and general 
emotional and cognitive functioning alongside sleep in a TS sample. It is hoped that this will 
give more information about sleep disturbance and its potential functional implications in TS 
as well as some insight into a possible mechanism for different learning processes in this group 
(i.e. altered consolidation) 
2.3 Study rationale, aims and hypotheses 
The present study therefore aims to add to the growing body of literature on sleep in 
children with TS in several ways. Firstly, it will be the first study to the author’s knowledge to 
objectively assess naturalistic sleep using actigraphy in this group. Secondly, based on the work 
of Kirov et al (2014) and Modaferri et al (2016), relationships will be explored between sleep 
disturbance and symptoms of a range of psychological disorders, as assessed by the Revised 
Children’s Anxiety and Depression Scale (RCADS; Chorpita, Moffitt & Gray, 2005). Thirdly, 
based on initial suggestions of different associations between sleep and learning in TS and 
healthy samples (Kirov et al., 2017) we will use a set of novel cognitive learning tasks to 
explore associations between sleep and consolidation in these groups. 
The study has three primary hypotheses:  
1. Children with TS will have more sleep difficulties than typically developing control 
participants.  
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2. Sleep difficulties will be associated with symptoms of various psychological disorders in 
both groups but this effect will be more pronounced in TS.  
3. Increased sleep disturbance will be associated with poorer performance on novel 
overnight cognitive learning tasks for both the TS and control groups. It is unknown 


































3.1 Ethical approval 
This study was approved by King’s College London Psychiatry, Nursing and Midwifery 
Research Ethics Committee (REC) on 23/12/2015 (Study Reference: HR15/162278; Appendix 
7). Approval was granted by the Health Research Authority REC Camden and King’s Cross 
committee on 15/05/2016 (Study reference: 16/LO/0393; Appendix 8). 
3.2 Power analysis 
Power analysis was conducted a priori using the software GPower. To our knowledge 
no existing studies have explored both sleep and learning using a between-groups design in 
either children or adults with TS. The most closely-related studies in samples of children with 
TS have considered sleep disruption. With this in mind using the effect of sleep vs wakefulness 
for the effect of memory consolidation in typically developing children (Wilhelm, Diekelmann 
& Born, 2008) requires a sample size of 12 participants, with power (1-β) at 80% and α at .05, 
two tailed. For the effect of disrupted vs non-disrupted sleep in TS requires a sample size of 32 
participants (16 per condition) based on the mean number of awakenings after sleep onset 
(Kostanecka-Endress et al, 2003) with power (1-β) set at 0.80 and α at .05, one-tailed.   
3.3 Recruitment and participants 
TS participants were recruited through the Tics and Neurodevelopmental Movements 
(TANDeM) clinic at Evelina London and online advertisements from the charity ‘Tourette 
Action’. Control participants were recruited through advertisements on the King’s College 
research circular, a listing on the Guy’s and St Thomas’ Hospital Foundation Trust intranet and 
by contacting community organisations and schools (see Appendix 1 for recruitment letter). 
Following initial expression of interest, participants were screened according to the inclusion 
criteria. Once eligibility was established children and parents were sent information sheets. 
Those recruited through the TANDeM clinic were sent sheets A to C (Appendix 2) while others 
were sent the relevant sheets from D to G (Appendix 3). Interested children and parents were 
then sent consent forms (Appendices 4 and 5) to sign. After giving informed consent a letter 
was sent to the General Practitioner (GP) of participants recruited through the TANDeM clinic 
to inform them of their patient’s participation (Appendix 6). 
3.3.1 Inclusion and exclusion criteria 
Participants were included if they were male, aged between 11 and 14 at the time of 
the study and had a current diagnosis of TS or CTD. Exclusion criteria included a diagnosis of 
ASD, Learning Disability (defined as a full-scale intelligence quotient (FSIQ) score <70), or 
changes to any prescribed medications within three months of participating. If children took 
Melatonin to aid sleep, they were asked not to do so for the study period. Participants were 
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not excluded on the basis of presence of comorbid ADHD as, due to the high comorbidity 
between ADHD and TS, this was not felt to be clinically-representative.  
3.4 Materials and measures 
3.4.1 Tic severity 
Tic severity was measured using the Yale Global Tic Severity Scale (YGTSS; Leckman, 
Riddle, Hardin, Ort, Swartz, Stevenson & Cohen, 1989). This semi-structured clinician-rated 
instrument assesses the nature of tics historically and currently. It also includes ratings of the 
number, frequency, intensity, complexity and interference of motor and phonic tics in 
categories scored from 0 (none/absent) to 5 (e.g. always present/severe intensity) giving a 
range of 0-25 for overall motor and phonic tic severity and a total tic severity score of 0-50. 
The functional impairment caused by tics is also scored on a 0-50 scale. Global severity can be 
calculated by combining total tic score with the impairment rating giving an overall score from 
0 to 100. The YGTSS is widely accepted as gold standard for paediatric tic assessment due to 
high internal consistency and stability of scores over time (Storch, Murphy, Geffken, Sajid, 
Allen, Roberti & Goodman, 2005).  
3.4.2 Sleep 
Participants wore an actigraph (Phillips Actiwatch Spectrum Pro) on their non-
dominant wrist continuously for 14 days with an epoch length of 30 seconds. Outputs were 
downloaded from each watch onto a corresponding software package (Actiware software 
package v 6.0) for analysis. Measures calculated were sleep onset latency, sleep efficiency 
percentage (sleep duration/sleep period) and minutes of wake after sleep onset (WASO). The 
researcher (CH) was trained in actigraphy administration and analysis by technicians from the 
Evelina London sleep clinic prior to the study commencing. During the first contact with the 
researcher, participants were given the actiwatch along with a set of information sheets and a 
sleep diary (appendix 9). Participants were instructed to keep the diary for the duration of the 
sleep study. The measure used was developed by the Evelina London sleep clinic and is 
routinely used clinically to aid actigraphy interpretation. 
3.4.3 Overnight learning 
Overnight learning was assessed using the ‘Sleepsuite’ games; this set of novel iPad-
based tasks were developed by a member of the research team (PG). The games were 
designed specifically to assess consolidation, while being engaging and enjoyable for children. 
They are currently being validated in various clinical and non-clinical populations. 
Three games were selected for the current project; these included a verbal learning 
task (the ‘Animals’ task), a continuous performance task (CPT; the ‘Balloons’ task), and a 
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spatial learning task (the ‘Mazes’ task). The games are introduced by a fictional character, 
‘Lou’, who guides players through each task (see Figure 1 for graphics).  
Animals task: Participants learn the names of 12 animals (e.g. ‘Perla the owl’). They are 
asked to recall these after a twelve minute break. The task is assessed based on recall after this 
interval, and then following a period of sleep. 
Balloons task (Rosenberg-Kima & Sadeh, 2010): In this CPT participants must detect 
target stimuli among a set of distractors. The game shows a lake from which ‘balloons’ filled 
with pictures of a diverse set of children’s faces showing different expressions emerge. 
Participants must ‘pop’ balloons with their finger according to certain rules designed to assess 
consolidation of emotion and gender information: 
Balloons emotion: Players are instructed to ‘pop all of the happy faces’ 
Balloons gender: Instructions are to ‘pop all of the girls’ faces’ 
Stimuli presentation speeds up during the task. The task is the same pre- and post- 
sleep and is scored on the number of commission errors made during each trial.  
Mazes task: (Nguyen, Tucker, Stickgold & Wamsley, 2013) Participants must memorise 
a 2D map, which they must then follow within a 3D maze to reach a ball of fire; the task is 
scored based on navigation speed. 
3.4.4 Cognition 
To check for any differences in cognitive functioning between groups, various domains 
of cognition were assessed using a standardised battery of neuropsychological measures. The 
battery was designed to give a comprehensive overview of intellectual functioning. A summary 





Figure 1: Graphics for the Sleepsuite Animals, Balloons and Mazes tasks 
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Table 1: Cognitive test battery 
Measure Domain of interest 
Wechsler Abbreviated Scale of Intelligence, 2nd edition (WASI-II; 
Wechsler, 2011) 2 subtest version 
IQ  
Cancellation (subtest from Wechsler Intelligence Scale for 
Children, 4th edition; WISC-IV; Wechsler, 2003)  
Processing speed & selective 
attention  
Block Recall (subtest from Working Memory Test Battery for 
Children; WMTB-C; Gathercole & Pickering, 2001)  
Visuo-spatial working memory  
Digit Span (subtest from WISC-IV; Wechsler, 2003)  Verbal working memory  
California Verbal Learning Test for Children (CVLT-C; Delis, 
Kramer, Kaplan & Ober, 1994)  
Verbal learning and memory  
Colour-word interference (subtest from Delis-Kaplan Executive 
Functioning System; DKEFS; Delis, Kaplan & Kramer, 2001) 
Verbal inhibition  
Walk, don’t walk (subtest from Test of Everyday Attention for 
Children; TEA-Ch; Manly, Robertson, Anderson & Nimmo-Smith, 
1998)  
Motor inhibition  
Grooved Pegboard Test (Klove, 1963) Visuo-motor coordination  
Blending Words (subtest from Comprehensive Test of 
Phonological Processing, second edition; CTOPP-2; Wagner, 
Torgesen, Rashotte & Pearson, 2013)  
Phonological Awareness  
 
3.4.5 Emotional and behavioural functioning 
Perception of emotional functioning and quality of life was assessed with a range of 
standardised questionnaires administered to young people and their parents or guardians. 
Parents of TS participants were also administered the YGTSS (described in section 3.4.1) to 
assess tic severity. An overview of the questionnaires administered is included below (Table 2) 
and further information about each can be found in Appendix 11.   
Table 2: Questionnaire battery 
3.5 Procedure 
Once children and parents had provided written consent to participate in the study, 
the researcher arranged to visit participants at home or school to administer the cognitive 
battery and questionnaires. For this reason, participants were only recruited if they lived in a 
location accessible to the researcher (i.e. in the south of England). Participants were given the 
Measure  Respondent and domain  
Conners 3rd edition (Conners, 2008) Parent report  
ADHD symptoms  
Strengths and Difficulties Questionnaire (SDQ; 
Goodman, 1997)  
Self-report and parent report  
General wellbeing  
Revised Children’s Anxiety and Depression Scale 
(RCADS; Chorpita et al., 2005)  
Self-report and parent report  
Anxiety and depression symptoms  
Paediatric Quality of Life (PedsOL; Varni, Seid & Rode, 
1999)  
Self-report and parent report  
General quality of life  
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actiwatch and accompanying paperwork (see Appendix 9) at this appointment and instructed 
to wear the actiwatch for 14 days and nights. If available, participants were given an iPad and 
instructions to complete the Sleepsuite tasks before and after a single night of sleep. If an iPad 
was not available at this time, one was sent to participants as soon as possible. Every 
participant completed the tasks within one month of their sleep study. Following the final 
study day all equipment was collected from participants and the data was scored and analysed 
by the researcher. 
3.6 Statistical analysis 



























4.1 Preliminary analyses 
The data was screened to check for normality, to look for outliers (mean ± ≥3.29 (z 
score)) and to examine missing values. Normality was inspected with histograms and Q-Q 
plots. Sleepsuite data was further screened and any values considered to represent non-
compliance (extreme or implausible scores) were excluded from this section of the analysis. 
These were determined by studying z-scores and box plots to look for outlying scores. Based 
on recommendations from previous uses of the Balloons task by the developer (PG) this 
measure was further assessed for noncompliance. Recommendations are that values 
considered to reflect implausible performance (high commission + low omission errors) should 
be excluded. Three control participants were excluded from Balloons analysis for implausible 
scores but could be included in the remainder of the analysis. Homogeneity of variance was 
assessed with Levene’s test before using parametric tests.  
 
4.2 Sample characteristics 
32 young adolescent males participated in the present study, this sample included a 
group with TS (n=16) and a group of typically developing control children (n=16). 51 additional 
children expressed interest in participating but could not be included for the following reasons: 
diagnosis of ASD/LD (n=11), outside age range (n=12), female (n=3), lived too far away (n=25). 
Following this careful initial screening by the researcher, the remaining 32 participants all met 
inclusion criteria so could be included in the analysis. Characteristics of the sample are 
displayed in Table 3. The groups did not differ in age [t(30)=.165, p=.870], but there were 
differences in the time they participated in the two week sleep study. More TS than control 
children took part during term-time (68.8% vs 31.3%). Half of the control group participated 
during both term and holiday (i.e. a week of holiday and a week of term; 50% of controls vs 
25% of TS)2. TS participants were recruited in equal numbers from the TANDeM clinic at 
Evelina London (50%) and through the charity Tourette Action (50%), while over half of control 
participants (56%) were recruited through schools3.  
4.2.1 Tic severity 
For the TS group, tic severity was assessed using the YGTSS. Tic severity ranged from 6-42 with 
a mean score within the ‘moderate’ range of 26.2. Overall impairment scores ranged from 6-
82, with a mean of 50.2, which is also considered moderate. Independent samples t-tests 
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 Independent samples t-tests showed no significant difference between actigraphy results dependent 
on recruitment source. 
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showed no significant difference in overall tic severity or associated functional impairment 
between participants recruited from the clinic as compared to charity recruits (see appendix 
12 for full scores).  
Table 3 Sample demographics 
 
4.2.2 Cognitive test results 
Results from the cognitive assessment battery for the TS and control groups are 
displayed in Table 4. Independent samples t tests confirmed that the groups did not 
significantly differ on any of the measures administered.  
4.2.3 Emotional and behavioural functioning scores 
Questionnaire results for each group are displayed in Table 4. TS participants were 
rated as having significantly more symptoms of ADHD hyperactive-impulsive type than controls 
[t(26)=3.26, p=.003]. The TS group was also rated as having significantly more psychosocial 
difficulties [SDQ self: t(26)=3.01, p=.006; SDQ parent: t(26)=2.76, p=.01], more symptoms of 
anxiety and depression [RCADS self: t(12.83)=2.12, p=.054; RCADS parent: t(26)=3.24, p=.003] 
and lower QoL [PedsQL self: t(15.62)=-2.86, p=.011; PedsQL parent: t(26)=-2.45, p=.021] than 
control participants. However, had Bonferroni corrections been performed on this data to 
control for multiple comparisons, the adjusted significance level would be .006. With this 
adjusted value, remaining significant differences between groups would be on the self-rated 
SDQ, parent-rated RCADS and Conner’s hyperactive-impulsive scores. 
 
 
  TS (n=16) 
Range (M, SD) or n(%) 
Control (n=16) 
Range (M, SD) or n(%) 
Age (years)  11-14 (12.3,1.25) 11-14 (12.2,0.85) 
Time of participation Term-time 
School holidays 
























 Table 4 Neuropsychological battery and questionnaire scores by group  
Domain Measure TS M(SD) Control M(SD) Statistics 
IQ 2-subtest IQ (WASI) 105.07 (16.09) 109.19 (11.85) t(30)= -0.82, p=.416 
Processing speed Cancellation (WISC-IV) 11.94 (2.23) 11.82 (3.12) t(30)= 0.13, p=.897 
Verbal  working memory 
Visuo-spatial  working memory 
Digit span (WISC-IV) 





t(30)= 1.05, p=.300 
t(29)= 0.49, p=.627 
Verbal learning and memory CVLT-C  short delay free recall 





t(29)= -0.30, p=.976 
t(29)= 0.48, p=.634 
Verbal inhibition 
 
Colour-word interference: Inhibition 






t(30)= -1.53, p=.136 
Motor inhibition Walk, don’t walk (TEA-Ch) 7.75 (3.94) 7.69 (3.34) t(30)= 0.48, p=.962 
Visuo-motor co-ordination Grooved pegboard: dominant hand 





t(29)= 0.31, p=.760 
t(29)= 0.88, p=.388 
Phonological awareness Blending words (CTOPP) 6.79 (3.50) 8.43 (3.26) t(26)= -1.29, p=.209 
Questionnaire Respondent TS M, SD (% in clinical range) Control M, SD (% in clinical range) Statistics 
Strengths and Difficulties 
Questionnaire (SDQ)-total  
Self 
Parent 
14.84, 6.63 (56.3%) 
14.69, 6.88 (43.8%) 
8.53, 4.38 (6.3%) 
8.33, 5.31 (18.8%) 
t(26)= 3.01, p=.006** 
t(26)= 2.76, p=.01* 
Revised Children’s Anxiety and 
Depression Scale (RCADS) 
Total anxiety and depression: Self 
Parent 
49.90, 15.89 (43.8%) 
60.84, 13.67 (50%) 
39.07, 6.96 (6.3%) 
47.13, 8.46 (12.5%) 
t(12.83)= 2.12, p=.054 
t(26)= 3.24, p=.003** 




69.72%, 17.73 (53.8%) 
61.92%, 21.63 (56.3%) 
85.84%, 9.14 (6.3%) 
78.40%, 13.49 (18.8%) 
t(15.62)= -2.86, p=.011* 
t(26)= -2.45, p=.021* 
Conner’s-3 ADHD inattentive 
ADHD hyperactive/impulsive 
67.47, 17.91 (50%) 
76.31, 17.01 (81.3%) 
55.87, 13.70 (18.8%) 
56.87, 14.56 (37.5%) 
t(26)= 1.94, p=.064 
t(26)= 3.26, p=.003** 
 * significant at p<.05 ** significant at p<.005    
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4.3 Main analysis 
4.3.1 Hypothesis 1: Children with TS will have more sleep difficulties than typically 
developing control participants.  
As Figure 2 shows, contrary to this hypothesis, there were no significant differences in 
sleep parameters between groups. This was confirmed with independent samples t-tests. 
Furthermore, Pearson’s correlations showed no association between tic severity and sleep 
disturbance for the TS group. However, exploring the data further shows that TS participants 
had more variable sleep onset latency (SoL) than controls, reflected in the 95% confidence 
intervals displayed as error bars on Figure 2. The majority of TS scores fell between 18 and 71 
minutes (range=53 minutes), while most controls took between 27 and 53 minutes to fall 
asleep (range=26 minutes).  
WASO=wake after sleep onset 
4.3.2 Hypothesis 2: Sleep difficulties will be associated with symptoms of psychological 
disorders in both groups, but this effect will be more pronounced in TS. 
Pearson’s correlations were conducted to explore relationships between sleep 
parameters and measures of emotional and behavioural functioning (see Appendix 13 for full 
results). The hypothesis was partially supported as in the TS group, SoL was found to be 
significantly associated with self-ratings of panic disorder symptoms [RCADS self: r=.639, 
p=.034] and parent rated depression [RCADS parent: r=.630, p=.028]. Sleep efficiency (SE) and 
wake after sleep onset (WASO) were not significantly associated with any of measures of 
emotional functioning in either group. 
Figure 2: Actigraphy results by group 




4.3.3 Hypothesis 3: Increased sleep disturbance will be associated with poorer 
performance on novel overnight cognitive learning tasks for both the TS and control groups. 
Whether this effect differs between groups will be explored. 
4.3.3.1 Overnight change in performance 
Before this hypothesis could be addressed, two-way repeated measures analyses of 
variance (ANOVA) were run to explore overall overnight change in performance between 
groups. These results are displayed in Table 5. No significant between-group differences were 
observed in performance change score (post-pre score) for any task. Trends in change scores 
are discussed below. 
Table 5 Mean performance on Sleepsuite tasks pre- and post-sleep 
On the Animals task, neither group showed a clear performance change overnight. On 
the Mazes task both groups took longer to reach the target post- as compared to pre-sleep. 
For the Balloons emotion task performance in both groups improved overnight, more for 
controls than TS (controls=8 less errors; TS=4 less errors) although this difference was not 
significant [F(1, 23)=.240, p=.628]. On the Balloons gender task the opposite pattern was seen 
as both groups made more errors post-sleep (controls=11 more errors; TS=5 more errors) 
although this was not significantly different between groups [F(1, 23)=.349, p=.561]. 
4.3.3.2 Associations between SoL and Sleepsuite performance 
The actigraphy variable used to represent sleep disturbance was SoL. This was 
expected to be the most sensitive measure of sleep difficulty in this sample because it was 
most different between groups and was the only sleep variable associated with 
psychopathology. The hypothesis was explored using a set of simple linear regressions and 
results are presented in Table 6. 
 
 TS  Controls  




Pre-sleep mean (SD) Post-sleep mean 
(SD) 
F(df) p d 
Animals (number correct) 7.85 (2.12) 7.31 (2.32) 6.80 (3.38) 6.27 (2.84) .000 (1,26) .995 .000 






38.38 (33.42) 34.54 (26.91) 35.58 (29.72) 27.58 (24.44) .240 (1, 23) .628 .010 
19.54 (22.94) 24.85 (14.12) 21.25 (12.88) 32.50 (23.93) .349 (1, 23) .561 .015 
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Table 6 Associations between SoL and Sleepsuite task performance 
 TS Controls 
Sleepsuite task B R R
2
 P B R R
2
 p 
Animals (number correct) -.026 .574 .329 .040* .007 .058 .003 .851 






















                                                                                               *=significant at p<.05 
On the Animals task, longer SoL was significantly predictive of poorer performance for 
TS participants, explaining 33% of the variance in scores on this task [R2=.329, F(1, 11)=5.40, 
p=.04]. For controls the effect was in the opposite direction but non-significant [R2=.003, F(1, 
11)=.037, p=.851].  
On the Mazes task, SoL was not significantly associated with performance for either 
group [TS: R2=.132, F(1, 11)=1.68, p=.222; Controls: R2=.016, F(1, 11)=.004, p=.950] but 
increased onset latency tended to be associated with worse performance post-sleep for both 
TS and control participants.  
On the Balloons emotion task, SoL was not significantly associated with performance 
for either group. However in general, longer SoL was associated with less errors post- as 
compared to pre-sleep for TS [R2=.015, F(1, 11)=.169, p=.689] and control groups [R2=.003, F(1, 
9)=.030, p=.867]. For the Balloons gender task, SoL was not significantly associated with 
performance for either group. Looking at the trend in the data, however, shows that longer 
SoL was associated with reduced errors post-sleep for both groups. This effect was stronger for 
controls [R2=.104, F(1, 9)=1.05, p=.333] than for the TS group [R2=.000, F(1, 11)=.004, p=.951] 
4.4. Post-hoc analysis: Relationships between cognitive performance and sleep 
Following the main analysis, it was of interest whether Sleepsuite performance would 
be associated with neuropsychological test scores differently for each group. Pearson’s 
correlations were run to explore this and full results are presented in Appendix 14. Significant 
associations were observed for the TS group between processing speed and the Animals task 
[r=.639, p=.019], between reaction time and Mazes task performance [r=.597, p=.03] and 
between inhibition and Balloons gender [r=-.626, p=.022]. No significant associations were 





5.1 Summary of aims and findings 
This study builds on recent research (Modaferri et al., 2016; Weisner et al., 2017; Kirov 
et al., 2017) by exploring the functional impact of sleep difficulties and associations between 
sleep, wellbeing and learning in children with TS and healthy controls. Overall, no significant 
differences in sleep parameters were observed between groups although TS participants had 
more variable onset latency than controls. For the sample of children with TS, longer onset 
latency was also associated with significantly more psychosocial difficulties and poorer 
learning performance on a verbal memory task. No significant associations emerged between 
sleep, psychopathology and learning for control participants. Trends in the data are suggestive 
of different overnight learning profiles, which may be linked to different underlying cognitive 
mechanisms between groups.  
5.1.1 Sleep in TS 
Contrary to predictions, this study found no significant differences in sleep parameters 
between children with TS and healthy controls. Furthermore, no significant associations 
emerged between sleep parameters and parent-rated tic severity or tic-related impairment. 
Considered within the context of the already inconclusive evidence base for sleep problems in 
children with TS (Hibberd et al., 2017) the present findings do not support hypotheses that 
sleep disturbance is a central aspect of this disorder (Kirov et al., 2007) or that sleep and tics 
are directly linked. Instead, the findings of delayed sleep onset and a subsequent fairly 
efficient night of sleep for some children are more in line with suggestions that tics are 
ameliorated during sleep (Hashemiyoon et al., 2017). Despite the lack of significant differences 
in sleep between groups, TS participants did have more variable sleep than controls. This 
suggests that this group may be more at risk of disturbance than their typically developing 
peers, especially around sleep onset. It will therefore be important to consider factors which 
lead certain members of this potentially ‘at risk’ group to experience problematic sleep. 
One previous suggestion is that sleep difficulties in TS are linked to medication use 
(Ayalon et al., 2002). Although this was not an exclusionary criteria for the present study, 
children were only able to participate following three months of pharmacological stability. This 
was felt by the expert authors (TH & PG) to be an adequate period for any adjustment-related 
medication effects (which may include sleep disturbance) to settle. It may therefore be that 
the sleep of children in the present sample was less affected by medications than in previous 
research (Hibberd et al., 2017) and could explain the lack of significant sleep disturbance 
found. More explicit explorations of this (i.e. directly comparing medicated to medication-
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naïve children) in future studies will allow clearer conclusions to be drawn regarding the 
impact of medications on sleep in TS.  
The lack of difference in sleep observed in the present study may also be at least 
partially due to aspects of the study itself. Most TS participants were monitored during term-
time, while many of the controls were partly or solely monitored during holidays, a time when 
sleep tends to be less routine than normal (Danker-Hopfe, 2011). Participants’ sleep-logs 
supported this, showing that during holidays many children had sleepovers and late evening 
social events, staying away from home and being permitted to wake later than during term-
time. Although no statistically significant differences were observed in sleep parameters 
depending on time of participation, this nonetheless may have exerted some effect on the 
results and so should be controlled for in future. 
Furthermore, as mentioned, this is the first study to have monitored sleep in children 
with TS using actigraphy as opposed to questionnaires or laboratory-based PSG methods. It 
may be that the particular types of sleep disturbance experienced by this group are not 
accurately detected by standard actigraphy. Indeed if children do tic overnight, it could be with 
less force than during the day or may occur in different parts of the body than the arm to 
which the actigraph is fastened (i.e. leg, facial or trunk tics; Galland et al., 2014). This could be 
further explored using overnight video-monitoring or multi-site accelometry where multiple 
actigraphs are fastened to different areas of the body (Galland et al., 2014). Although this 
would compromise some of the naturalistic benefits to actigraphy, and complicates a method 
which is attractive because of its simplicity, it would give richer information about whole-body 
motion during sleep. Additionally, a standardised sleep questionnaire was not administered to 
the present sample due to concerns that another measure may lead to participant fatigue and 
questionnaire non-compliance. However, without a subjective report qualitative aspects of 
sleep habits as well as family and child perceptions of sleep disturbance could not be explored. 
It will be helpful for future researchers to utilise mixed method paradigms (i.e. concurrent 
objective and subjective methods of sleep assessment) where possible to allow the most 
holistic understanding of the nature of sleep disturbance in this population to emerge (Gregory 
& Sadeh, 2016).  
5.1.2 Associations between sleep and functioning 
5.1.2.1 Psychopathology 
Along with medication use another factor suggested to be related to sleep disturbance 
in children with TS is the presence of comorbid psychopathological conditions (Allen et al., 
1992). In line with this, the most variable sleep parameter in the present study (sleep onset 
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latency; SoL) was significantly associated with symptoms of panic disorder and depression for 
TS participants but not for controls. While depression has previously been associated with 
sleep disturbance in this group (Modaferri et al., 2016), to our knowledge the relationship with 
panic has not been observed before. The TS-specific nature of these relationships suggests a 
particular mechanism linking these psychological disorders to sleep disturbance in this clinical 
group. Although the reasons for this are unclear, one possibility is that neuropathological 
changes underpinning both TS and comorbid disorders increase susceptibility to poor sleep. 
Indeed, neural changes across CSTC circuits as well as alterations to transmission of DA, 5-HT, 
GABA and glutamate have been observed in TS patients, as well as in those with depression 
and panic disorder (Mink, 2001; Santos, D’Amico & Dierssen, 2015; Peters et al., 2016). 
Importantly, these neural systems also facilitate sleep-wake regulation (Beebe, 2012). 
Although neurobiological changes are therefore likely to be one factor linking sleep, TS, 
depression and panic disorder, if the relationship were purely neurological associations would 
also be expected between TS, sleep and other conditions characterised by CSTC abnormalities 
(e.g. OCD; Ahmari, Spellman, Douglass, Kheirbek, Simpson, Deisseroth et al., 2013).   
It may be that although the relationship involves neuropathological vulnerabilities, 
these only affect sleep within the context of particular psychological mechanisms. One 
candidate mechanism is adoption of a bias towards an internal focus of attention, or 
‘interoception’. Interoception has been found to be a common feature of TS (Pile, Lau, Topor, 
Hedderly & Robinson, 2017) and may be linked to tracking the premonitory urges which 
precede tics (Robinson & Hedderly, 2016). Similarly, in panic disorder catastrophic 
misinterpretations of bodily symptoms are thought to lead to a state of interoceptive 
hypervigilance (Yoris, Esteves, Couto, Melloni, Kichic, Cetkovich et al., 2015), while depressed 
patients show heightened interoception linked to a ruminative style of information processing 
(Shankman, Nelson, Sarapas, Robison-Andrew, Campbell, Altman, McGowan et al., 2013; 
Hamm, Richter & Panné-Farré, 2014; Northoff & Sibille, 2014; Paulus & Stein, 2010). The 
inherent threat appraisals associated with interoception in these disorders might cause 
feelings of anxiety, which could then activate the HPA axis and cause cortisol release, 
hyperactivity of which has previously been linked to sleep disturbance in TS (Buse et al., 2014; 
Corbett et al., 2008). It may therefore be that children with TS who are prone to interoception 
focus on internal sensations pre-sleep, possibly linked to concerns about tics occurring, causing 
physiological hyperarousal and subsequently delaying sleep onset. Although intriguing, this 
proposed mechanism is extremely tentative and necessitates further investigation in projects 





This was the first direct study of overnight consolidation in children with TS. Despite 
recent findings that TS patients and controls show opposing relationships between REM sleep 
duration and measures of neurobehavioural functioning (Kirov et al., 2017) it was unknown 
whether the specific process of consolidation would differ between these groups. It was also 
not known whether performance would be affected by aspects of the task or stimuli as in 
other neurodevelopmental disorders (e.g. reduced salience effect in ADHD; Weisner et al., 
2017). Although effects were largely non- significant, exploring trends in the data uncovered 
opposing patterns of performance on the verbal learning Animals task. While overall overnight 
performance change did not differ, SoL was significantly associated with performance for TS 
participants, with longer latency linking to worse performance; this effect was in the direction 
that would be expected. Unexpectedly however, the opposite effect was observed for 
controls, with longer SoL being linked to better performance following a night of sleep.  
The reasons for this dissociation are unclear, however this task was the first to be 
administered post-sleep. With this in mind, it may be that typically developing populations 
show higher levels of inertia (post-wake disorientation following long sleep periods; Sadeh et 
al., 2002) than children with TS. In support of this, performance on cognitive tasks completed 
soon after wake is thought to be regulated by interactions between inertia, circadian rhythms 
and homeostatic processes (Burke, Scheer, Ronda, Czeisler & Wright, 2015). In clinical 
populations where these systems are affected (i.e. homeostasis in TS, Godar & Bortolato, 
2016) the balance between these processes is likely to differ and this might then impact on 
task performance. In the present study both groups also took longer to complete the Mazes 
task of spatial learning following sleep, thus suggesting slower reaction times post-wake. This 
could be considered support for the impact of inertia on performance. Inertia may therefore 
affect cognition in a domain-specific manner, exerting a global effect across clinical and 
typically developing populations for certain skills (i.e. reaction speed) but differentially 
affecting others (i.e. verbally-mediated memory tests). 
Group differences were also observed in the magnitude of changes on the continuous 
performance (Balloons) tasks. Although TS and controls showed effects in the same direction 
on both Balloons tasks, controls showed more of an improvement than TS on the emotion task, 
and more of a negative change on the gender task after sleep. This task was also more strongly 
associated with SoL for controls relative to TS participants. Unlike previous studies of children 
with ADHD (Weisner et al., 2017) there did not appear to be any particular effect of the 
salience of stimuli (i.e. emotion vs gender) within this task in children with TS and no 
significant association between performance and ADHD symptoms in this group. While this 
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could be suggestive of disorder-specific consolidation patterns across neurodevelopmental 
disorders, it may also reflect task-related or methodological differences between studies. To 
allow further clarification of the disorder-specificity of altered consolidation processes and rule 
out potential methodological confounds, future studies should aim to directly compare groups 
of children with different neurodevelopmental profiles and matched healthy control groups on 
the same consolidation task. 
Following observation of different performance patterns on the Animals task and 
magnitude of performance change on the Balloons tasks, it was wondered whether Sleepsuite 
performance might be underpinned by different cognitive skills between groups. This 
suggestion appeared to have some support. While no significant associations emerged 
between task performance and neuropsychological scores for controls, within the TS group 
significant associations were observed between processing speed, reaction time, inhibition and 
consolidation performance. This seems to suggest that children with TS rely more strongly on 
underlying cognitive skills to facilitate this process than their typically developing peers. Within 
the current actigraphy paradigm the neural mechanisms underpinning this could not be 
elucidated. However, extending the present findings to facilitate understanding of 
consolidation within the context of sleep stages will be a key task for future studies. 
It is recognised that different types of information are consolidated during different 
sleep stages (e.g. SWS for episodic declarative memories and REM for emotional information; 
Walker, 2009; Weisner et al., 2015). This process has also been found to occur differently in 
ADHD and typically developing children (Prehn-Kristensen et al., 2011). Previous PSG studies 
have reached inconclusive results regarding sleep stage changes in children with TS, which is 
thought to be linked to methodological and sampling heterogeneity across studies (Hibberd et 
al., 2017). Thus, there is a need for larger-scale, more demographically varied and rigorously 
conducted projects that track associations between sleep stage distribution and processes of 
overnight consolidation in children with TS.  These studies could also consider the ‘sleep 
spindle’ as another potential factor underpinning consolidation differences between clinical 
and non-clinical groups. This electroencephalographic event is generated by a thalamocortical 
neural network during stage two of sleep (Fogel & Smith, 2011) and is highly correlated with 
general cognitive abilities, processes of consolidation and learning efficiency (Hoedlmoser, 
Heib, Roell, Piegneux, Sadeh, Gruber & Schabus, 2014). Considering the characteristic 
thalamocortical changes in TS (Mink, 2001) and the different learning profiles observed in the 





5.2 Future research 
Along with the ideas extending the current findings already proposed in this report, it 
would be useful to conduct more studies focusing on causes of sleep difficulties in TS. One way 
of doing this would be through conducting longitudinal studies tracking sleep in a single TS 
cohort over time. This would also allow more explicit testing of the theory proposed by Kirov 
et al (2014) that tics, sleep and neurobehavioural functioning are reciprocally related. Such 
studies could specifically look at factors which have been suggested to contribute to poor 
sleep in this group (e.g. physiological hyperarousal, Modafferi et al., 2016). This could be 
undertaken by testing markers of circadian regulation (e.g. cortisol levels) alongside sleep to 
see if these offer an explanation of sleep variability in TS (Honomichl et al., 2002).  
Another interesting direction for future research would be to continue considering the 
functional implications of sleep difficulties in this group. One potential focus would be if, and 
how, sleep disturbance might translate into specific functional problems (i.e. with classroom 
learning or peer and social relationships) in TS. For instance, in ADHD attentional difficulties 
have been proposed to be amplified by sleep-dependent problems with memory and 
consolidation (Prehn-Kristensen et al., 2011). Although TS is not consistently associated with 
learning problems, and within the present sample no profile of cognitive impairment was 
observed, children with sleep disturbance within the context of TS may learn differently or 
show a different pattern of tic-related daytime symptoms to those who sleep well. For these 
studies it would be helpful to specifically recruit children with TS who report sleep disturbance 
as this would give more idea of the clinical characteristics and functional performance of this 
sample.  
5.3 Strengths and limitations 
This study has extended previous research into sleep in children with TS. It included a 
representative sample of TS participants recruited both from clinical and community settings 
and an age-, gender- and IQ-matched healthy control group. It controlled carefully for effects 
of adjustment to medication and thoroughly assessed other clinically relevant factors, 
including tic severity and psychopathology, using validated measures. It is the first study to 
have used actigraphy to explore sleep profiles in children with TS as well as drawing on 
research in other neurodevelopmental populations about possible daytime implications of 
sleep disturbance in this group. The findings offer initial insights into relationships between 
sleep and various functional domains in TS as well as into the process of overnight 
consolidation in this clinical group. It is hoped that these preliminary findings will be 
elaborated on in future projects. 
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Nonetheless, in line with the naturalistic and exploratory nature of this study, the 
findings should be interpreted cautiously. A key limitation of this project is the modest sample 
size. Furthermore, although age and gender were intentionally controlled for and the sample 
was designed to be clinically representative, it may not have been reflective of the most sleep-
disturbed TS group. It has been suggested that sleep problems are most prevalent in TS around 
the age of 7 years (Sadeh et al., 2002) and that female patients may have more disturbed sleep 
than males (Storch et al., 2009). Additionally, because early adolescence is characterised by 
changes and maturation of sleep patterns (Barclay & Gregory, 2014), disturbances may be 
more likely at this developmental stage regardless of clinical status. Factors such as gender, 
age, ethnicity and socio-economic status have been acknowledged to impact on sleep and 
learning in typically developing populations (Sadeh et al., 2002). It would be helpful for future 
studies to recruit larger and more demographically diverse samples to allow the impact of 
these factors in TS to be more fully understood. 
The method of consolidation assessment is another limitation of this study. The 
Sleepsuite tasks are novel and not yet validated, although this research is in progress. To the 
author’s knowledge they have not previously been used in a naturalistic study (i.e. outside of 
the laboratory). One seemingly problematic consequence of this was that outside of the 
laboratory, children did not appear to always be compliant with the Balloons tasks, leading to 
several implausible results. This reduced the power of an already modest sample, rendering 
interpretations of the learning data tentative. It will be helpful to consider ways in future 
studies to further incentivise participation and help to increase participant effort on such tasks. 
It should also be highlighted that there was no significant difference in sleep between groups. 
It may therefore be that different conclusions regarding learning performance would be 
reached in the context of more problematic sleep. 
5.4 Clinical implications 
A key implication of the present findings is that sleep outcomes were not significantly 
different between samples of children with TS and healthy peers. This suggests that sleep 
difficulties are not an inevitable consequence of having TS as some children slept as well as, or 
better than, controls. Nonetheless, there was more evidence for variability in sleep in the TS 
group, suggesting that this group may be more ‘at risk’ of difficulties falling asleep than 
typically developing peers. This means that systematic screening of sleep should be an 
essential part of consultations with TS patients.  Furthermore, sleep difficulties were related to 
symptoms of depression and panic disorder in TS children. This may mean that when sleep 
problems are highlighted, children could also be at risk of comorbid psychopathology, which 
should be explored further. Taking this integrated approach and considering sleep and 
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emotional functioning concurrently is in line with the notion that understanding sleep is 
central to understanding and enhancing wellbeing (Harvey et al., 2011; Maski & Kothare, 
2013). 
It is also hoped that when sleep and/or psychopathological difficulties have been 
screened for and identified they could be managed with targeted interventions. The most 
significant sleep disturbances in the present sample related to sleep onset, which were also 
specifically associated with psychopathology. The pre-sleep period may therefore be a key 
time at which interventions could be targeted. Indeed, Kirov et al (2014) have suggested that 
anxiety and subsequent cortisol release and muscle tension should be targeted within any 
intervention designed to improve sleep quality in TS. Simple behavioural and muscular 
relaxation strategies could therefore be routinely shared with children in clinical consultations. 
This may prevent or manage sleep onset problems early in their clinical course and thus 
minimise their functional impact.   
5.5 Conclusions 
This exploratory and novel study represents a first step towards characterising natural 
sleep patterns in a representative sample of children with TS. Sleep was highly variable in the 
clinical group but overall was not significantly different to the control group. This highlights the 
importance of screening these children for sleep difficulties especially around sleep onset, but 
suggests that sleep disturbance may not be a central aspect of TS. Children most at risk of poor 
sleep appeared to be those with TS and comorbid symptoms of psychological disorders (i.e. 
panic disorder, depression), which may be linked to interoceptive tendencies in this group. 
Tentative conclusions have been made regarding different patterns of learning and 
information consolidation in TS children compared to healthy controls, as well as around 
different associations between learning and cognition in this group. It is hoped that these 
initial suggestions will stimulate further research with the aim of improving detection and 
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Appendix 1: Recruitment letter 
We are writing to you with regard to participation in a research study being conducted as part 
of the Chief Investigator’s Doctorate in Clinical Psychology. The project is investigating how 
quality of sleep might be linked with learning, behaviour and mood in children. We are 
particularly interested in exploring how these factors interact in young people with Tourette 
syndrome and Chronic Tic Disorders, compared to a similar group of students without these 
diagnoses. The findings of this study are anticipated to enhance our understanding of the 
relationship between sleep and learning during development, with the aim of informing future 
interventions 
We are looking to recruit boys aged between 11 and 14 years to take part in the study. This 
includes both typically developing boys and boys with tic disorders. 
The project involves wearing a particular type of watch, known as an actigraphy watch, during 
the day and at night for two weeks. The watch monitors the wearer’s movement and this 
information will be used to learn about how well they are sleeping. To look at learning, the 
student will also be required to play some specially designed memory games on an iPad, one 
evening and then again the next morning. Both the watch and the iPad will be provided by our 
team. Participants will also be asked to complete some questionnaires and some standard 
tests to assess intellectual functioning and other cognitive skills. This one-off assessment is 
expected to take no more than two hours. Where possible, we are hoping to complete these 
assessments in a school setting.  
To thank students for their participation, they will each receive a £10 Amazon voucher. We are 
unable to offer schools any financial incentive for assisting with participation, however, we 
hope you will be able to assist us with this project as it is an opportunity to be part of an 
exciting research project in a much needed area of study. Once the study is finished we will be 
able to send you a summary report of the study’s findings, highlighting your schools invaluable 
involvement in the study.  
We are very respectful of the pressures put upon students, and teachers alike, but hope that 
you will be able to help us with this project. If you have any queries, or would be interested in 





Charlotte Hibberd                                             
Trainee Clinical Psychologist and Chief Investigator                              
Addiction Sciences Building   
Institute of Psychiatry, Psychology and Neuroscience (IoPPN) 









Information sheet for participants aged 11-14  
‘A naturalistic study investigating sleep and cognitive learning in children with  
and without tic disorders’ 
(Version 4; 07/04/2016) 
 
We would like to ask you to take part in a postgraduate research study 
looking at sleep and learning in children with Tourette Syndrome or Chronic 
Tic Disorders. You should only take part if you want to and if you don’t, 
that’s absolutely fine - it will not affect you in any way! Before you decide 
if you want to take part, it is important you understand what is involved. 
Please read this sheet carefully, and talk to your parents about it. Ask if 
you would like some more information. 
1. What is this about? 
We would like to find out more about sleep in children with Tourette 
Syndrome or Chronic Tic Disorder, and if difficulties with sleep affect 
learning, mood and behaviour. People with Tourette Syndrome or Chronic 
Tic Disorder have ‘tics’, which are sudden repeated sounds or movements 
which can occur in any part of your body and can change over time. These 
findings will help us to help children with Tourette Syndrome or Chronic Tic 
Disorders with sleep problems. We will be comparing the results from this 
study to findings from children without Tourette syndrome and Chronic Tic 
Disorders. 
2. Why are you asking me? 
We are asking boys aged 11 to 14 with a diagnosis of Tourette Syndrome or 
Chronic Tic Disorder to take part in the study - it doesn’t matter if you 
think you’re a good or bad sleeper! If you don’t want to take part, that’s 
absolutely fine. And if you say yes, then decide you don’t want to do it 
anymore, that’s absolutely fine too. It’s totally up to you. We will also ask 





3. What will happen if I say yes? 
First, we will ask you and your parent/carer to come to Evelina Children’s 
Hospital, or we will come to visit you at your home or school. This is so that 
you can answer some questions and do some different thinking puzzles, 
which most children say are quite fun! 
We will then give you two things to take home. 
1. A special watch that will look a bit like this  
You will need to wear this watch in the day and at night for 2 
weeks, so that it can collect information to tell us how you’re 
sleeping. The watch is quite small so you will probably 
completely forget you’re wearing it!  
2. An iPad that has a special app with games on it.  
 
We will ask you to take this home for a night and play the 
games one night before you go to bed, and then again 
when you wake up the next morning. We’ve heard from 
other children that these are pretty good fun!  
 
The data from the study will be kept anonymously (so no-one will know that 
your results are yours) for up to 7 years. 
 
4. What’s good about doing this? 
The study will help us learn about sleep in children with Tourette Syndrome 
and Chronic Tic Disorders, so we can offer other children who have these 
conditions better support and treatments. We also hope that the games 
and puzzles will be fun! 
5. Could anything bad happen to me? 
We don’t think so. However, if you did feel upset or worried by anything, 
we will make sure there is someone for you to talk to about it. We will also 
be asking you some questions about your emotions (e.g. if you are a worrier 
or someone who gets sad about things). It’s normal for everyone to feel 
worried or sad sometimes, but if we thought that you might feel more 
upset by things than others, we would want to try and make sure you have 
some help with this. To do this, we would first talk to you and your parents, 





6. Who will know I’ve done this?  
Your parents/carers, your GP (who is your everyday doctor), the doctors 
working in the TANDeM clinic at the Evelina Hospital and maybe also some 
of the teachers at your school will be the only people other than me who 
will know you’ve taken part. We won’t tell any other doctors you might see. 
7. How do I find out more?  
If you want to know anything else after reading this sheet, you can speak 
to your parents/carers or contact me using the contact 
details:  
Charlotte Hibberd 
Trainee Clinical Psychologist 
Addiction Sciences Building, Institute of Psychiatry, 
Psychology and Neuroscience (IoPPN) 






















THANK YOU for reading this information 
sheet and thinking about taking part!  
As another thank you for taking part, after 
the 2 weeks of the study you will be given a 










INFORMATION SHEET FOR PARENTS OF PARTICIPANTS (Version 4; 11/04/2016) 
 
REC Reference Number: 16/LO/0393 
 
YOU WILL BE GIVEN A COPY OF THIS INFORMATION SHEET 
 
This information sheet is for parents of participants with Tourette Syndrome/Chronic 
Tic Disorder 
 
‘A naturalistic study investigating sleep and cognitive learning in children with and 
without tic disorders’ 
 
In this postgraduate research project, we are investigating how sleep might affect 
learning, behaviour and mood in children with Tourette Syndrome and Chronic Tic 
Disorders. This is important because we know that many children with Tourette 
Syndrome or Chronic Tic Disorders have problems getting to sleep, staying asleep, or 
do not have very good quality sleep. We also know that sleep is important for learning, 
and may also affect behaviour and mood. We would like to invite you and your child to 
be part of this study, but before you decide whether to take part, it is important that 
you understand why we are doing the study and what will be involved. Please 
remember that you do not have to take part in the study.  Please take time to read this 
information carefully and discuss it with others if you wish. If anything is not clear, or 
you have any more questions after reading this, please ask.  
 
1. What are we trying to find out? 
We want to investigate (by monitoring your child’s sleep, assessing thinking skills and 
completing questionnaires) how sleep affects learning, behaviour and mood in children 
with Tourette Syndrome/Chronic Tic Disorder. We will be comparing the results from 
this study to findings from children without Tourette syndrome and Chronic Tic 
Disorders. People diagnosed with Tourette Syndrome or Chronic Tic Disorder 
experience ‘tics’, which are sudden repeated movements or vocalisations. Tics can 
occur in any part of the body and often change over time. Some people have tics which 
are very obvious and noticeable, while in other people they can be much less visible.  
These findings will help us to help other children and young people with sleep 
problems with and without Tourette syndrome and Chronic Tic Disorders.     
 
2. Why has my child been asked to take part? 
We are asking boys aged 11 to 14 years who have a diagnosis of Tourette 
Syndrome/Chronic Tic Disorder and their parents to take part. As the study involves 
completing questionnaires, if you think that either you or your child will struggle to 
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understand and complete the questionnaires even with help (e.g. from you or the 
researcher) then we ask that you do not take part or let them take part.   
 
If you decide that you and your child can take part, you are free to withdraw at any 
time without giving a reason. A decision not to take part, or to withdraw, will not affect 
you or your child in terms of healthcare or education. If you have any questions about 
this project and what you are being invited to take part in then please ask the 
researcher before you decide whether to participate. In addition to withdrawing 
you/your child from the study, you may also withdraw any data/information you/they 
have already provided up until 1st October 2016. 
 
3. What will my child be asked to do? 
You and your child will first be asked to complete some questionnaires about mood 
and general wellbeing, and your child will be asked to do some thinking puzzles, this 
will take about one to two hours and can either be done at the Evelina Children’s 
Hospital, or at your child’s school or your home, depending on what is easiest for you. 
Your child will then be asked to wear a special watch to monitor their sleep during the 
day and at night for 2 weeks. Before going to sleep on one of these nights and again 
when they wake up the next morning, we will ask your child to complete some puzzles 
on an iPad that we will provide. The games are designed for children, are meant to be 
fun, and take no more than 30 minutes to complete. Answers are completely private, 
and answers and scores will not be shared with anyone else. 
 
4. Are there any benefits of taking part? 
The study will have no direct benefit to you or your child, however the main benefit is 
being part of a study that will help us understand about sleep, learning and mood in 
young people with and without a diagnosis of Tourette Syndrome/Chronic Tic 
Disorder. This knowledge will help us develop targeted interventions for children with 
sleep problems. We will also be able to provide you and your child with information 
about sleep, learning and mood and where to seek support related to any of these 
areas, if needed.  
 
5. Are there any risks? 
The project does not have any likely risks associated with it. If your child does experience any 
distress related to the study at any point, there will always be someone available for them to 
talk to, or ask questions to. We will also routinely inform participants General 
Practitioners (GPs) of their involvement with the study so they will be aware of your 
child’s participation should any difficulties arise.   
 
Everything you and your child tell us is private and confidential. However, if either you or your 
child tells us something that means we are worried that there might be risk to you/them (e.g. 
that someone is hurting you/them) then we would need to break confidentiality. We would 
offer you/your child support and assist you/them to access appropriate help which will 
include writing to your GP for further assessment or support via a local Child and 
Adolescent Mental Health Service (CAMHS). If you are ever worried about yourself or your 






6. Will our participation be kept confidential? And how will our information be 
kept? 
To ensure confidentiality, your child will be randomly allocated a code. This unique 
code will be used on all questionnaires, measures and throughout data analysis so that 
no personally identifiable information will ever be associated directly with their data. If 
you and your child decide to take part, your consent form will be kept separately from 
their data and in a locked filing cabinet which only the main researchers will be able to 
access. Confidentiality will only be broken in the unlikely event that your child 
indicates potential harm to themselves or to others as it is the researcher’s duty to 
pass on this information. In this case, the researcher would speak with you and 
possibly your GP, if necessary. Details will be kept for up to 7 years at King’s College 
London, and then destroyed. 
 
7. What happens afterwards? 
The results of the study will increase our understanding of the relationship between 
sleep and learning in children and help us to develop interventions targeting difficulties 
in these areas. The results will also be submitted for publication but no personally 
identifiable information will be included in this. Please let the researcher know if you 
wish to receive a copy of the published article.  
 
8. What if there is a problem? 
If you have a concern about any aspect of this study, you should ask to speak to the 
researchers who will do their best to answer your questions [Charlotte Hibberd, 
charlotte.hibberd@kcl.ac.uk]. If you remain unhappy and wish to complain formally, 
you can do this through the Guy’s and St Thomas’ Patients Advice and Liaison Service 
(PALS) on 020 7188 8801, pals@gstt.nhs.uk. The PALS team are based in the main 
entrance on the ground floor at St Thomas’ Hospital and on the ground floor at Guy’s 
Hospital in the Tower Wing.  
In the event that something does go wrong and you are harmed during the research 
you may have grounds for legal action for compensation against Guy’s and St Thomas’ 
NHS Foundation Trust and/or King’s College London but you may have to pay your 
legal costs. The normal National Health Service complaints mechanisms will still be 
available to you (if appropriate). 
 
9. How do I find out more?  
If you have any further questions after reading this sheet, you can 
contact me at any time:  
 
Charlotte Hibberd 
Trainee Clinical Psychologist 
Addiction Sciences Building, Institute of Psychiatry, Psychology and 
Neuroscience (IoPPN) 





If this study has harmed you or your child in any way you can contact King's College 







Thank you for reading this information sheet and considering taking part. 
 
As another thank you for taking part we will reimburse your family for your time 























































INFORMATION SHEET FOR PARENTS OF PARTICIPANTS: (Version 1; 12/04/2016) 
 
REC Reference Number: 16/LO/0393 
  
YOU WILL BE GIVEN A COPY OF THIS INFORMATION SHEET 
 
This information sheet is for parents of participants about their participation in the project 
 
‘A naturalistic study investigating sleep and cognitive learning in children with and without 
tic disorders’ 
 
In this postgraduate research project, we are investigating how sleep might affect learning, 
behaviour and mood in children.  
 
Please see the enclosed information sheet for further information about the background to 
the project, and what your child would be required to do if they decided to participate.  
 
This extra information sheet aims to help you understand what would be required of you as a 
parent or guardian if your child takes part. Please remember that you and your child do not 
have to take part in the study. Please also take time to read this information carefully and 
discuss it with others if you wish. If anything is not clear, or you have any more questions after 
reading this, please ask Charlotte Hibberd using the contact details listed at the end of the 
page.  
 
1. What will I be asked to do? 
Your part in the study involves two main elements, completing a short diary of your child’s 
sleep patterns for the two weeks they are in the study, and completing a set of questionnaires 
about their general mood and wellbeing. These elements will now be outlined in more detail. 
 
1. The sleep diary is a short measure which asks you to note down the time your child 
goes to sleep and wakes up. It is important that you try to be as accurate as you can 
with this, although we do know it’s sometimes hard to be totally exact! The diary also 
asks you to write down things like how many caffeinated drinks your child drinks in a 
day, and how much exercise they have done, which might affect how they’re sleeping. 
These questions will help us to interpret the data from the watch your child would be 
wearing for the study. This measure is designed to be brief and hopefully should not 
take more than a few minutes to fill out each day. 
 
2. Both you and your child will also be asked to complete some questionnaires. These 
include questions about your child’s mood and general wellbeing, their behaviour and 
also about their symptoms of Tourette Syndrome/Chronic Tic Disorder. The 
questionnaires should not take a long time to complete and can either be done at the 
Evelina Children’s Hospital (while you wait for your child to complete the ‘thinking 
puzzle’ part of the study, if you choose for them to do this at the hospital), or we can 
send them to you in the post to be completed at home.  Charlotte Hibberd will be 
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contactable by email throughout your child’s involvement with the study, and will be 
able to answer any further questions you might have about these questionnaires. 
 
We will not be asking you any questions which are specifically about your own wellbeing, as all 
of the questionnaires will focus on your child’s functioning.  
 
Your answers will be kept completely private and confidential. However, if either you or your 
child tells us something that means we are worried that there might be risk to you/them (e.g. 
that someone is hurting you/them) then we would need to break confidentiality. We would 
offer you/your child support and assist you/them to access appropriate help. We will also be 
informing your GP of your child’s involvement in the study, so that if you are at all worried 
about yourself or your child then you can contact your GP for further advice.    
 
If you have any further questions after reading this sheet, or if you would like any more 
information about your involvement with it, you can contact me at any time:  
 
Charlotte Hibberd 
Trainee Clinical Psychologist 
Addiction Sciences Building, Institute of Psychiatry, Psychology and Neuroscience (IoPPN) 





If this study has harmed you or your child in any way you can contact King's College London 




























Information sheet for participants with Tourette syndrome 
 or Chronic Tic Disorder 
We would like to ask you to take part in a postgraduate research study 
looking at sleep and learning in children with Tourette syndrome or Chronic 
Tic Disorders. You should only take part if you want to and if you don’t, 
that’s absolutely fine - it will not affect you in any way! Before you decide 
if you want to take part, it is important you understand what is involved. 
Please read this sheet carefully, and talk to your parents about it. Ask if 
you would like some more information. 
1. What is this about? 
We would like to find out more about sleep in children with Tourette 
syndrome or Chronic Tic Disorder, and if difficulties with sleep affect 
learning, mood and behaviour. These findings will help us to help children 
with Tourette syndrome or Chronic Tic Disorders with sleep problems. We 
will be comparing the results from this study to findings from children 
without Tourette syndrome and Chronic Tic Disorders. 
2. Why are you asking me? 
We are asking boys aged 11 to 14 with a diagnosis of Tourette syndrome or 
Chronic Tic Disorder to take part in the study - it doesn’t matter if you 
think you’re a good or bad sleeper! If you don’t want to take part, that’s 
absolutely fine. And if you say yes, then decide you don’t want to do it 
anymore, that’s absolutely fine too. It’s totally up to you. We will also ask 
your parent or carer whether they are happy for you to take part in the 
study. 
3. What will happen if I say yes? 
First, we will come to visit you at your home or school. This is so that you 
can answer some questions and do some different thinking puzzles, which 
most children say are quite fun! 
We will then give you two things to take home. 
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A special watch that will look a bit like this  
You will need to wear this watch in the day and at night for 2 weeks, so 
that it can collect information to tell us how you’re sleeping. The watch is 
quite small so you will probably completely forget you’re 
wearing it!  
An iPad that has a special app with games on it.  
We will ask you to take this home for a night and play the 
games one night before you go to bed, and then again 
when you wake up the next morning. We’ve heard from 
other children that these are pretty good fun!  
 
4. What’s good about doing this? 
The study will help us learn about sleep in children with Tourette syndrome 
and Chronic Tic Disorders, so we can offer children who have these 
problems better support and treatments. We also hope that the games and 
puzzles will be fun. 
5. Could anything bad happen to me? 
We don’t think so. However, if you did feel upset or worried by anything, 
we will make sure there is someone for you to talk to about it.  
6. Who will know I’ve done this?  
Your parents/carers, the doctors working in the TANDeM clinic at the 
Evelina Hospital and maybe also some of the teachers at your school will be 
the only people other than me who will know you’ve taken part. We won’t tell 
any other doctors you might see. 
7. How do I find out more?  
If you want to know anything else after reading this sheet, you can speak 
to your parents/carers or contact me using the contact 
details:  
Charlotte Hibberd 
Trainee Clinical Psychologist 
Addiction Sciences Building, Institute of Psychiatry, 
Psychology and Neuroscience (IoPPN) 









































THANK YOU for reading this information sheet and 
thinking about taking part!  
As a thank you for taking part, after the 2 weeks of 







INFORMATION SHEET FOR PARENTS OF PARTICIPANTS 
 
REC Reference Number: HR15/162278 
 
YOU WILL BE GIVEN A COPY OF THIS INFORMATION SHEET 
 
This information sheet is for parents of participants with Tourette Syndrome/Chronic 
Tic Disorder 
 
‘A naturalistic study investigating sleep and cognitive learning in children with and 
without tic disorders’ 
 
In this postgraduate research project, we are investigating how sleep might affect 
learning, behaviour and mood in children with Tourette Syndrome and Chronic Tic 
Disorders. This is important because we know that many children with Tourette 
Syndrome or Chronic Tic Disorders have problems getting to sleep, staying asleep, or 
do not have very good quality sleep. We also know that sleep is important for learning, 
and may also affect behaviour and mood. We would like to invite you and your child to 
be part of this study, but before you decide whether to take part, it is important that 
you understand why we are doing the study and what will be involved. Please 
remember that you do not have to take part in the study.  Please take time to read this 
information carefully and discuss it with others if you wish. If anything is not clear, or 
you have any more questions after reading this, please ask.  
 
1. What are we trying to find out? 
We want to investigate (by monitoring your child’s sleep, assessing thinking skills and 
completing questionnaires) how sleep affects learning, behaviour and mood in children 
with Tourette Syndrome/Chronic Tic Disorder. We will be comparing the results from 
this study to findings from children without Tourette syndrome and Chronic Tic 
Disorders. These findings will help us to help other children and young people with 
sleep problems with and without Tourette syndrome and Chronic Tic Disorders.     
 
2. Why has my child been asked to take part? 
We are asking boys aged 11 to 14 years who have a diagnosis of Tourette 
Syndrome/Chronic Tic Disorder and their parents to take part. As the study involves 
completing questionnaires, if you think that either you or your child will struggle to 
understand and complete the questionnaires even with help (e.g. from you or the 
researcher) then we ask that you do not take part or let them take part.   
 
If you decide that you and your child can take part, you are free to withdraw at any 
time without giving a reason. A decision not to take part, or to withdraw, will not affect 
you or your child in terms of healthcare or education. If you have any questions about 
this project and what you are being invited to take part in then please ask the 
researcher before you decide whether to participate. In addition to withdrawing 
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you/your child from the study, you may also withdraw any data/information you/they 
have already provided up until 1st October 2016. 
 
3. What will my child be asked to do? 
You and your child will first be asked to complete some questionnaires about mood 
and general wellbeing, and your child will be asked to do some thinking puzzles, this 
will take about one to two hours and can either be done at your child’s school or your 
home, depending on what is easiest for you. Your child will then be asked to wear a 
special watch to monitor their sleep during the day and at night for 2 weeks. Before 
going to sleep on one of these nights and again when they wake up the next morning, 
we will ask your child to complete some puzzles on an iPad that we will provide. The 
games are designed for children, are meant to be fun, and take no more than 30 
minutes to complete. Answers are completely private, and answers and scores will not 
be shared with anyone else. 
 
4. Are there any benefits of taking part? 
The main benefit is being part of a study that will help us understand about sleep, 
learning and mood in young people with and without a diagnosis of Tourette 
Syndrome/Chronic Tic Disorder. This knowledge will help us develop targeted 
interventions for children with sleep problems. We will also be able to provide you and 
your child with information about sleep, learning and mood and where to seek support 
related to any of these areas, if needed. We will also reimburse your family for your 
time with a £10 Amazon voucher.  
 
5. Are there any risks? 
The project does not have any likely risks associated with it. If your child does 
experience any distress related to the study at any point, there will always be someone 
available for them to talk to, or ask questions to.  
Everything you and your child tell us is private and confidential. However, if either you 
or your child tells us something that means we are worried that there might be risk to 
you/them (e.g. that someone is hurting you/them) then we would need to break 
confidentiality. We would offer you/your child support and assist you/them to access 
appropriate help. If you are ever worried about yourself or your child then you can 
contact your GP for further advice.    
 
6. Will our participation be kept confidential? And how will our information be 
kept? 
To ensure confidentiality, your child will be randomly allocated a code. This unique 
code will be used on all questionnaires, measures and throughout data analysis so that 
no personally identifiable information will ever be associated directly with their data. If 
you and your child decide to take part, your consent form will be kept separately from 
their data and in a locked filing cabinet which only the main researchers will be able to 
access. Confidentiality will only be broken in the unlikely event that your child 
indicates potential harm to themselves or to others as it is the researcher’s duty to 
pass on this information. In this case, the researcher would speak with you and 
possibly your GP, if necessary. Details will be kept for up to 7 years at King’s College 
London, and then destroyed. 
 
7. What happens afterwards? 
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The results of the study will increase our understanding of the relationship between 
sleep and learning in children and help us to develop interventions targeting difficulties 
in these areas. The results will also be submitted for publication but no personally 
identifiable information will be included in this. Please let me know if you wish to 
receive a copy of the published article.  
 
8. How do I find out more?  
If you have any further questions after reading this sheet, you can 
contact me at any time:  
 
Charlotte Hibberd 
Trainee Clinical Psychologist 
Addiction Sciences Building, Institute of Psychiatry, Psychology and 
Neuroscience (IoPPN) 





If this study has harmed you or your child in any way you can contact King's College 
London using the details below for further advice and information: 
 
Professor Tony Charman 
0207 848 5038 Charlotte Hibberd 
Tony.charman@kcl.ac.uk                                                          
charlotte.hibberd@kcl.ac.uk 
 






















Information sheet for participants  
We would like to ask you to take part in a postgraduate research study 
looking at sleep and learning. You should only take part if you want to and if 
you don’t, that’s absolutely fine-it will not affect you in any way! Before you 
decide if you want to take part, it is important you understand what is 
involved. Please read this sheet carefully, and talk to your parents about it. 
Ask if you would like some more information. 
1. What is this about? 
We would like to find out more about children’s sleep, and if difficulties 
with sleep affect learning, mood and behaviour. These findings will help us 
to help children with sleep problems. We will be comparing the results from 
this study to findings from children with Tourette syndrome and Chronic 
Tic Disorders. 
2. Why are you asking me? 
We are asking boys aged 11 to 14 to take part in the study. It doesn’t 
matter if you think you’re a good or bad sleeper! If you don’t want to take 
part, that’s absolutely fine. And if you say yes, then decide you don’t want 
to do it anymore, that’s absolutely fine too. It’s totally up to you.  
We will also ask your parent or carer whether they are happy for you to 
take part in the study. 
3. What will happen if I say yes? 
First, we will come to your home or school so that you can answer some 
questions and do some different thinking puzzles, which most children say 
are quite fun! We will then give you two things to take home. 
A special watch that will look a bit like this. You will need to wear 
this watch in the day and at night for 2 weeks, so that it 
can collect information to tell us how you’re sleeping. The 
watch is quite small so you will probably completely forget you’re 




An iPad that has a special app with games on it. We will ask 
you to take this home for a night and play the games one 
night before you go to bed, and then again when you wake 
up the next morning. We’ve heard from other children that 
these are pretty good fun!  
 
4. What’s good about doing this? 
The study will help us learn about children’s sleep, so we can offer children 
who have sleep problems better support and treatments. We also hope that 
playing the games and puzzles will be fun. 
5. Could anything bad happen to me? 
We don’t think so. However, if you did feel upset or worried by anything, 
we’d make sure there is someone for you to talk to about it.  
6. Who will know I’ve done this?  
Your parents/carers, the doctors working in the TANDeM clinic at the 
Evelina Hospital and maybe also some of the teachers at your school will be 
the only people other than me who will know you’ve taken part. We won’t tell 
any other doctors you might see. 
7. How do I find out more?  
If you want to know anything else after reading this sheet, you can speak 
to your parents/carers or contact me using the contact details:  
Charlotte Hibberd 
Trainee Clinical Psychologist 
Addiction Sciences Building, Institute of Psychiatry, 
Psychology and Neuroscience (IoPPN)  









THANK YOU for reading this information sheet and 
thinking about taking part!  
As a thank you for taking part, after the 2 weeks of 







INFORMATION SHEET FOR PARENTS OF PARTICIPANTS 
 
REC Reference Number: HR15/162278 
  
YOU WILL BE GIVEN A COPY OF THIS INFORMATION SHEET 
 
This information sheet is for parents of participants without Tourette 
Syndrome/Chronic Tic Disorder 
 
‘A naturalistic study investigating sleep and cognitive learning in children with and 
without tic disorders’ 
 
In this postgraduate research project, we are investigating how sleep might affect 
learning, behaviour and mood in children. This is important because we know sleep 
problems are common in children. We also know that sleep is important for learning, 
and may affect behaviour and mood. We would like to invite you and your child to be 
part of this study, but before you decide whether you would like to take part, it is 
important that you understand why we are doing this study and what will be involved. 
Please remember that you do not have to take part in the study. Please take time to 
read this information carefully and discuss is with others if you wish. If anything is not 
clear, or you have any more questions after reading this, please ask.  
 
1. What are we trying to find out? 
We want to investigate (by monitoring your child’s sleep, assessing thinking skills and 
completing questionnaires) how sleep affects learning, behaviour and mood in 
children. We will be comparing the results from this study to findings from children 
with Tourette syndrome and Chronic Tic Disorders. These findings will help us to help 
other children and young people with sleep problems with and without Tourette 
syndrome and Chronic Tic Disorders.     
 
2. Why has my child been asked to take part? 
We are asking boys aged 11 to 14 years (who do not have a diagnosis of Tourette 
Syndrome/Chronic Tic Disorder) and their parents to take part. As the study involves 
completing questionnaires, if you think that either you or your child will struggle to 
understand and complete the questionnaires even with help (e.g. from you or the 
researcher) then we ask that you do not take part or let them take part.   
 
If you decide that you and your child can take part, you are free to withdraw at any 
time without giving a reason. A decision not to take part, or to withdraw, will not affect 
you or your child in terms of healthcare or education. If you have any questions about 
this project and what you are being invited to take part in then please ask the 
researcher before you decide whether to participate. In addition to withdrawing 
you/your child from the study, you may also withdraw any data/information you/they 




3. What will my child be asked to do? 
You and your child will first be asked to complete some questionnaires about mood 
and general wellbeing, and your child will be asked to do some thinking puzzles, this 
will take about one to two hours and can either be done at your child’s school or your 
home, depending on what is easiest for you.  Your child will then be asked to wear a 
special watch to monitor their sleep during the day and at night for 2 weeks. Before 
going to sleep on one of these nights and again when they wake up the next morning, 
we will ask your child to complete some puzzles on an iPad that we will provide. The 
games are designed for children, are meant to be fun, and take no more than 30 
minutes to complete. Answers are completely private, and answers and scores will not 
be shared with anyone else. 
  
4. Are there any benefits of taking part? 
The study will have no direct benefit to you or your child. The main benefit is being 
part of a study that will help us understand about sleep, learning and mood in young 
people. This knowledge will help us develop targeted interventions for children with 
sleep problems. We will also be able to provide you and your child with information 
about sleep, learning and mood and where to seek support related to any of these 
areas, if needed. We will also reimburse your family for your time with a £10 Amazon 
voucher.  
 
5. Are there any risks? 
The project does not have any likely risks associated with it. If your child does 
experience any distress related to the study at any point, there will always be someone 
available for them to talk to, or ask questions to.  
 
Everything you and your child tell us is private and confidential. However, if either you 
or your child tells us something that means we are worried that there might be risk to 
you/them (e.g. that someone is hurting you/them) then we would need to break 
confidentiality. We would offer you/your child support and assist you/them to access 
appropriate help. If you are ever worried about yourself or your child then you can 
contact your GP for further advice.   
 
6. Will our participation be kept confidential? And how will our information be 
kept? 
To ensure confidentiality, your child will be randomly allocated a code. This unique 
code will be used on all questionnaires, measures and throughout data analysis so that 
no personally identifiable information will ever be associated directly with their data. If 
you and your child decide to take part, your consent form will be kept separately from 
their data and in a locked filing cabinet which only the main researchers will be able to 
access. Confidentiality will only be broken in the unlikely event that your child 
indicates potential harm to themselves or to others as it is the researcher’s duty to 
pass on this information. In this case, the researcher would speak with you and 
possibly your GP, if necessary. Details will be kept for up to 7 years at King’s College 






7. What happens afterwards? 
The results of the study will increase our understanding of the relationship between 
sleep and learning in children, and help us to develop interventions targeting 
difficulties in these areas. The results will also be submitted for publication but no 
personally identifiable information will be included in this. Please let the researcher 
know if you wish to receive a copy of the published article.  
 
 
8. How do I find out more?  






Trainee Clinical Psychologist 
Addiction Sciences Building, Institute of Psychiatry, Psychology and 
Neuroscience (IoPPN) 






If this study has harmed you or your child in any way you can contact King's College 
London using the details below for further advice and information: 
 
Professor Tony Charman 
0207 848 5038 Charlotte Hibberd 
Tony.charman@kcl.ac.uk                                                          
charlotte.hibberd@kcl.ac.uk 
 




















CONSENT FORM FOR PARTICIPANTS IN RESEARCH STUDIES (version 3; 
07/04/2016) 
 
Please complete this form after you have read the Information 
Sheet and/or listened to an explanation about the research. 
 
This consent form is for participants 
‘A naturalistic study investigating sleep and cognitive learning in 
children with and without tic disorders’ 
 
REC Reference Number: 16/LO/0393 
Thank you for thinking about taking part in this research. If you have any 
questions, please ask the researcher before you decide whether to join in. 
You will be given a copy of this consent form to take home and keep. 
Participant statement                                                                                  
I confirm that I understand that by ticking each box I am 
assenting to this part of the research. I understand that unticked 
boxes mean I DO NOT assent to that bit of the study. I 
understand that by not assenting to any one part, I might not be 
able to do the research at all. 
Name:                              
                                                                                                           Please tick 
1. I have read the information sheet dated 07/04/2016 for 
the above study. I have been able to think about it and ask 




2. I understand that it is up to me if I take part, and that 
even after it starts, I can decide to stop being in the study 
if I want to. 
 
3. I understand that no-one will be able to tell who I am from 











I confirm that I have carefully explained the nature and demands of this 
research study to the participant. 

































CONSENT FORM FOR PARENTS OF PARTICIPANTS IN RESEARCH STUDIES (version 2; 22/01/2016) 
Please complete this form after you have read the Information Sheet and/or 
listened to an explanation about the research. 
This consent form is for parents and carers 
‘A naturalistic study investigating sleep and cognitive learning in children with and 
without tic disorders’ 
REC Reference Number: 16/LO/0393 
Thank you for considering taking part in this research. The person organising the 
research must explain the project to you and your child before you can agree to take 
part. If you have any questions arising from the information sheet, or discussions with 
the researcher or clinical team, please ask the researcher before you decide whether 
to join in. You will be given a copy of this consent form for you to keep and refer to at 
any time. 
Parent/guardian statement                                                                                  
I confirm that I understand that by ticking/initialling each box I am consenting that my family 
can participate in this element of the study. I understand that it will be assumed that 
unticked/initialled boxes mean that I DO NOT consent to my family taking part in that part of 
                                                                                                                                                  Please tick/initial 
 
1. I have read the information sheet dated 22/01/2016 for the above study 
and have talked to a member of the research or clinical team about it. I 
have had the opportunity to consider the information and ask questions, 
which have been answered satisfactorily. 
 
 
2. I understand that my family’s participation is voluntary and that we are 
free to withdraw at any time, without giving reason, and without being 
affected in any way. Furthermore I understand that I will be able to 
request to withdraw the data until 1
st
 October 2016. 
 
 
3. I consent to the processing of their personal information for the purposes 
explained to me. I understand that such information will be handled in 
accordance with the terms of the UK Data Protection Act 1998.  
 
 
4. I understand that my/my families data may be subject to review by 
responsible individuals from Guy’s and St Thomas’ NHS Foundation Trust 
and King’s College London University. 
 
5. I understand that confidentiality and anonymity will be maintained and it 
will not be possible to identify us in any publications.  
 
6. I agree to be contacted in the future by King’s College London researchers 
who would like to invite me to take part in follow up studies to this 










the study. I understand that by not giving consent for any one element, my child may be 
deemed ineligible for the study. 
 







I confirm that I have carefully explained the nature and demands of this research study 
to the participant. 

























Appendix 5: Consent forms for non-NHS participants 
CONSENT FORM FOR PARTICIPANTS IN RESEARCH STUDIES 
 
Please complete this form after you have read the Information 
Sheet and/or listened to an explanation about the research. 
 
This consent form is for participants 
 
‘A naturalistic study investigating sleep and cognitive learning in 
children with and without tic disorders’ 
 
REC Reference Number: HR15/162278 
 
Thank you for thinking about taking part in this research. If you have any 
questions, please ask the researcher before you decide whether to join in. 
You will be given a copy of this consent form to take home and keep. 
Participant statement                                                                                  
I confirm that I understand that by ticking each box I am agreeing 
to this part of the research. I understand that unticked boxes 
mean I DO NOT agree to that bit of the study. I understand that 
by not agreeing to any one part, I might not be able to do the 
research at all. 
                                                                                                           Please tick 
1. I have read the information sheet dated 18/12/2015 for the 
above study. I have been able to think about it and ask 





Name:    





I confirm that I have carefully explained the nature and demands of this 
research study to the participant. 

















2. I understand that it is up to me if I take part, and that even 
after it starts, I can decide to stop being in the study if I 
want to. 
 
3. I understand that no-one will be able to tell who I am from 



















CONSENT FORM FOR PARENTS OF PARTICIPANTS IN RESEARCH STUDIES 
Please complete this form after you have read the Information Sheet 
and/or listened to an explanation about the research. 
This consent form is for parents and carers 
 
‘A naturalistic study investigating sleep and cognitive learning in 
children with and without tic disorders’ 
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REC Reference Number: HR15/162278 
Thank you for considering taking part in this research. The person organising the 
research must explain the project to you and your child before you can agree to take 
part. If you have any questions arising from the information sheet, or discussions with 
the researcher or clinical team, please ask the researcher before you decide whether 
to join in. You will be given a copy of this consent form for you to keep and refer to at 
any time. 
Parent/guardian statement                                                                                  
I confirm that I understand that by ticking/initialling each box I am consenting 
that my family can participate in this element of the study. I understand that it 
will be assumed that unticked/initialled boxes mean that I DO NOT consent to 
my family taking part in that part of the study. I understand that by not giving 
consent for any one element, my child may be deemed ineligible for the study. 
 
 
Name of parent/guardian:                                
 
                                                                                                                                       Please tick/initial 
 
1. I have read the information sheet dated 18/12/2015 for the above study and have 
talked to a member of the research or clinical team about it. I have had the 




2. I understand that my family’s participation is voluntary and that we are free to 
withdraw at any time, without giving reason, and without being affected in any 
way. Furthermore I understand that I will be able to request to withdraw the data 
until 1
st
 October 2016. 
 
 
3. I consent to the processing of their personal information for the purposes 
explained to me. I understand that such information will be handled in accordance 
with the terms of the UK Data Protection Act 1998.  
 
 
4. I understand that their information may be subject to review by responsible 
individuals from the college for monitoring and audit purposes. 
 
5. I understand that confidentiality and anonymity will be maintained and it will not 
be possible to identify us in any publications.  
 
6. I agree to be contacted in the future by King’s College London researchers who 
would like to invite me to take part in follow up studies to this project, or in future 















I confirm that I have carefully explained the nature and demands of this research study 
to the participant. 






























Tics and NeuroDevelopmental Movements 
 Children’s Neurosciences Centre 
Floor 1 (Lift/ Stairs D), South wing 
 St Thomas' Hospital 
Westminster Bridge Road 
London SE1 7EH 
 
Department: 020 7188 4661 
Fax: 020 7188 4629 
Main Switchboard: 020 7188 7188 
            
  
 
‘A naturalistic study investigating sleep and cognitive learning in children with 
and without tic disorders’ 
 
This letter is for information only and no action is required. It is to inform you that your 
patient _______________________________ is participating in a research project 
being conducted by researchers at King’s College London and Evelina London 
Children’s Hospital. The project is investigating how quality of sleep might be linked 
with learning, behaviour and mood in children with and without tic disorders. The 
findings of this study are anticipated to enhance our understanding of the relationship 
between sleep and learning during development, with the aim of informing future 
interventions.  
 
The project involves the participant wearing an actigraphy watch for two weeks to 
monitor movement and provide information about sleep quality. To look at learning, 
participants will be play specially designed memory games on an iPad, one evening 
and then again the next morning. Participants will also be asked to complete standard 
tests of intellectual functioning and other cognitive skills, as well as questionnaires 
about emotional and behavioural functioning.  
 
The study is not expected to have any adverse effects for participants. However, 
should your patient disclose any information that makes the research team concerned 
for their safety, or the safety of those around them, we will contact yourselves in the 
interests of safeguarding.   
 





Charlotte Hibberd                                             
Trainee Clinical Psychologist                              
Addiction Sciences Building   
Institute of Psychiatry, Psychology and Neuroscience (IoPPN) 
4 Windsor Walk, Denmark Hill 
London, SE5 8AF 
charlotte.hibberd@kcl.ac.uk 
 




Charlotte Hibberd  
  
23 December 2015  
Dear Charlotte,   
Study Title: A naturalistic study investigating sleep and cognitive learning in children with and without tic disorders  
Study Reference:  HR-15/16-2278  
I am pleased to inform you that full approval for your project has been granted by the Psychiatry, Nursing and Midwifery 
Research Ethics Subcommittee 
Please ensure that you follow all relevant guidance as laid out in the King's College London 
Guidelines on Good Practice in Academic Research 
(http://www.kcl.ac.uk/college/policyzone/index.php?id=247). 
For your information, ethical approval is granted until 23rd December 2018. If you need 
approval beyond this point, you will need to apply for an extension at least two weeks before 
this. You will be required to explain the reasons for the extension.   However, you will not need 
to submit a full re-application unless the protocol has changed.  If you have been granted 
approval for only 12 months, you will not be sent a reminder when it is due to lapse. 
Ethical approval is required to cover the data-collection phase of the study. This will be until 
the date specified in this letter.  However, you do not need ethical approval to cover 
subsequent data analysis or publication of the results. 
For secondary data-analysis, ethical approval is applicable to the data that is sensitive or 
identifies participants.   
Approval is applicable to period in which such data is accessed or evaluated. 
Please note you are required to adhere to all research data/records management and storage 
procedures agreed to as part of your application.  This will be expected even after the 
completion of the study.   
If you do not start the project within three months of this letter, please contact the Research 
Ethics Office.  
Please note that you will be required to obtain approval to modify the study.  This also 
encompasses extensions to periods of approval. Please refer to the URL below for further 
guidance about the process:  
http://www.kcl.ac.uk/innovation/research/support/ethics/applications/modifications.aspx 
Please would you also note that we may, for the purposes of audit, contact you from time to 
time to ascertain the status of your research.  
If you have any query about any aspect of this ethical approval, please contact the Research 
Ethics Office: (http://www.kcl.ac.uk/innovation/research/support/ethics/contact.aspx) 




James Patterson - Senior Research Ethics Officer 
For and on behalf of 
Professor Gareth Barker, Chair of the Psychiatry, Nursing and Midwifery Research Ethics Subcommittee   

























Appendix 8: Ethical approval letter from NHS REC 
 
  
London - Camden & Kings Cross Research Ethics Committee  
Room 001  
Jarrow Business Centre  
Rolling Mill Road  
Jarrow  
Tyne & Wear  
145 
 
NE32 3DT  
  
Telephone: 0207 104 8087  
  
  
16 May 2016  
  
Dr Sally Robinson  
Children's Neurosciences Centre, Floor 1 Staircase D South Wing  
St Thomas' Hospital  
Westminster Bridge Road  
London  
SE1 7EH  
  
 Dear Dr Robinson   
  
Study title:  A naturalistic study investigating sleep and cognitive 
learning in children with and without tic disorders  
REC reference:  16/LO/0393  
IRAS project ID:  191384  
  
Thank you for your letter of 03 May 2016, responding to the Committee’s request for further 
information on the above research and submitting revised documentation.  
The further information was considered in correspondence by a Sub-Committee of the REC. A 
list of the Sub-Committee members is attached.    
We plan to publish your research summary wording for the above study on the HRA website, 
together with your contact details. Publication will be no earlier than three months from the 
date of this opinion letter.  Should you wish to provide a substitute contact point, require 
further information, or wish to make a request to postpone publication, please contact the 
REC Manager, Miss Christie Ord at nrescommittee.london-camdenandkingscross@nhs.net.  
  
Confirmation of ethical opinion  
On behalf of the Committee, I am pleased to confirm a favourable ethical opinion for the 
above research on the basis described in the application form, protocol and supporting 
documentation as revised, subject to the conditions specified below.  
  
Conditions of the favourable opinion  
  
The REC favourable opinion is subject to the following conditions being met prior to the start 
of the study.  
Management permission must be obtained from each host organisation prior to the start of 
the study at the site concerned.  
  
Management permission should be sought from all NHS organisations involved in the study in 
accordance with NHS research governance arrangements. Each NHS organisation must confirm 
through the signing of agreements and/or other documents that it has given permission for the 
research to proceed (except where explicitly specified otherwise).   
Guidance on applying for NHS permission for research is available in the Integrated Research 




Where a NHS organisation’s role in the study is limited to identifying and referring potential 
participants to research sites (‘Participant Identification Centre’), guidance should be sought 
from the R&D office on the information it requires to give permission for this activity.  
  
For non-NHS sites, site management permission should be obtained in accordance with the 
procedures of the relevant host organisation.   
  
Sponsors are not required to notify the Committee of management permissions from host 
organisations  
  
Registration of Clinical Trials  
  
All clinical trials (defined as the first four categories on the IRAS filter page) must be registered 
on a publically accessible database within 6 weeks of recruitment of the first participant (for 
medical device studies, within the timeline determined by the current registration and 
publication trees).    
There is no requirement to separately notify the REC but you should do so at the earliest 
opportunity e.g. when submitting an amendment.  We will audit the registration details as part 
of the annual progress reporting process.  
To ensure transparency in research, we strongly recommend that all research is registered but 
for non-clinical trials this is not currently mandatory.  
If a sponsor wishes to contest the need for registration they should contact Catherine Blewett 
(catherineblewett@nhs.net), the HRA does not, however, expect exceptions to be made. 
Guidance on where to register is provided within IRAS.   
  
It is the responsibility of the sponsor to ensure that all the conditions are complied with 
before the start of the study or its initiation at a particular site (as applicable).  
  
Ethical review of research sites  
  
NHS sites  
The favourable opinion applies to all NHS sites taking part in the study, subject to management 
permission being obtained from the NHS/HSC R&D office prior to the start of the study (see 
‘Conditions of the favourable opinion’ above).  
Approved documents  
  
The final list of documents reviewed and approved by the Committee is as follows:  
Document    Version    Date    
GP/consultant information sheets or letters [GP_letter]   1   05 April 2016   
Letters of invitation to participant [Letter_to_schools]   1   20 November 2015  
Non-validated questionnaire [Sleep_diary]   1   19 November 2015  
Other [PG_brief_CV]   1   19 February 2016   
Other [TH_brief_CV]   1   19 February 2016   
Other [Information_letter_schools]   1   05 April 2016   
Participant consent form [Consent_form_parents]   2   22 January 2016   
Participant consent form [Consent_form_YP]   2   22 January 2016   
Participant consent form [Actiwatch_consent]   1   19 November 2015  
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Participant consent form [Consent_form_YP]   3   07 April 2016   
Participant information sheet (PIS) [Actiwatch_information_sheet]   1   19 November 2015  
Participant information sheet (PIS)  
[Information_sheet_parents_control]   
4   11 April 2016   
Participant information sheet (PIS) 
[Information_sheet_parents_TS]  
 4   11 April 2016   
Participant information sheet (PIS) [Parent_information_sheet]   1   12 April 2016   
Participant information sheet (PIS) 
[Information_sheet_YP_control]   
4   07 April 2016   
Participant information sheet (PIS) [Information_sheet_YP_TS]   4   07 April 2016   
REC Application Form [REC_Form_24022016]      24 February 2016   
Referee's report or other scientific critique report 
[Reviewer_report]   
1   18 October 2015   
Research protocol or project proposal [Protocol]   3   22 January 2016   
Summary CV for Chief Investigator (CI) [SR_CV]   1   29 January 2016   
Summary CV for student [CH_brief_CV]   1   19 February 2016   
Summary CV for supervisor (student research) [TC_brief_CV]   1   19 February 2016   
Validated questionnaire [Conners 3]         
Validated questionnaire [GTS-QoL]         
Validated questionnaire [MOVES]         
Validated questionnaire [PedsQL_parent_8-12]         
Validated questionnaire [PedsQL_parent_13-18]         
Validated questionnaire [PedsQL_YP_8-12]         
Validated questionnaire [PedsQL_YP_13-18]         
Validated questionnaire [RCADS_parent]         
Validated questionnaire [RCADS_self]         
Validated questionnaire [SDQ_parent]         
Validated questionnaire [SDQ_self]         
Validated questionnaire [YGTSS]         
Statement of compliance  
  
The Committee is constituted in accordance with the Governance Arrangements for Research 
Ethics Committees and complies fully with the Standard Operating Procedures for Research 
Ethics Committees in the UK.  
After ethical review  
  
Reporting requirements  
The attached document ‘After ethical review – guidance for researchers’ gives detailed 
guidance on reporting requirements for studies with a favourable opinion, including:  
  
• Notifying substantial amendments  
• Adding new sites and investigators  
• Notification of serious breaches of the protocol  
• Progress and safety reports  




The HRA website also provides guidance on these topics, which is updated in the light of 
changes in reporting requirements or procedures.  
User Feedback  
  
The Health Research Authority is continually striving to provide a high quality service to all 
applicants and sponsors. You are invited to give your view of the service you have received and 
the application procedure. If you wish to make your views known please use the feedback 
form available on the HRA website:  
http://www.hra.nhs.uk/about-the-hra/governance/quality-assurance/     
HRA Training  
  
We are pleased to welcome researchers and R&D staff at our training days – see details at 
http://www.hra.nhs.uk/hra-training/    
16/LO/0393                          Please quote this number on all correspondence  
  
With the Committee’s best wishes for the success of this project.  
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London - Camden & Kings Cross Research Ethics Committee  
  
Attendance at Sub-Committee of the REC meeting held in correspondence  
    
Committee Members:   
  
Name    Profession    Present     Notes    
Ms Petra Shroff   Paediatric Nurse   Yes       
Ms Eleni Yerolaki   Specialist Counsellor    Yes   Alternate Vice-Chair    
   
Also in attendance:   
  
Name    Position (or reason for attending)    

















The actiwatch you have been given is a device that monitors activity, both day 
and night. It should be worn like a watch continuously for the desired duration. 
It should only be removed if it is likely to get wet for example in the bath 
or when swimming. 
 
To ensure the actiwatch is attached correctly, please secure it to your child’s 
non dominant wrist (i.e. on their non-writing side).  
 
It will be “active” for the whole time and cannot be accidentally switched off. It 
is very important that it is put on as soon as it is received. 
 
To help get as much information as possible please complete the enclosed 
sleep log with as much detail as possible, including the start date and times of 
“lights out”/settling time.  
 
You should return the watch at the end of the two week monitoring period in 
line with the agreement you have made with the study team. This will either be 
via their school, by Special Delivery post, or will be collected from you by one of 
the research team. 
 
If you experience any problems or have any queries or concerns related to this 





Charlotte Hibberd                                             
Trainee Clinical Psychologist                              
Addiction Sciences Building   
Institute of Psychiatry, Psychology and Neuroscience (IoPPN) 
4 Windsor Walk, Denmark Hill 




Actiwatch with strap 
Sleep Log for home 









AMBULATORY SLEEP MONITORING: ACTIWATCH 
 
Participant number:  
DOB:  
Type of Actiwatch and S/N:  
 
Please read the following carefully before giving your consent. If you feel you are 
unable to abide by the terms and conditions of this loan you will not be issued this 
device and alternative arrangements will be necessary. 
 
1. The equipment is loaned to me and remains the property of the Guy’s and St 
Thomas’ NHS Foundation Trust, Evelina Children’s Hospital London at all times. 
2. I must take care of the equipment loaned to me. I will be responsible for 
replacement costs should any loss occur. 
3. I must return the equipment on the date indicated below. Failure to return the 






RETURN OF EQUIPMENT: 
 
The device must be returned at the end of your child’s study in line with the 
agreement you have made with the researchers. This will either be to their school, by 
Special Delivery post, or will be collected from you by one of the research team.  
Should you accidently lose or damage the watch it is important that you contact 
Charlotte Hibberd as soon as possible by emailing charlotte.hibberd@kcl.ac.uk. 
 
Please sign the below to indicate that you understand the conditions of the loan: 
 
Print name ……………………………………………………….. 
 




Print name ……………………………………………………….. 
 
Signed ..………………………………………………………  
 
 




To whom it may concern 
 
The owner of this letter is undergoing a research study and is wearing an 
actiwatch on their wrist. The purpose of the study is to discover more 
about the wearer’s sleep patterns by measuring day and night time 
activity for two weeks.  
 
The device does not make any noise and cannot be switched off 
accidentally. The only important thing to remember is that it’s not 
waterproof and needs to be removed before showers or swimming, kept 
in a safe place and put back on as soon as possible. It would be very 
useful if a note of any time the watch is removed can be made and 
handed back to the child or their parents at the end of the study. 
 






Charlotte Hibberd                                             
Trainee Clinical Psychologist                              
Addiction Sciences Building   
Institute of Psychiatry, Psychology and Neuroscience (IoPPN) 
4 Windsor Walk, Denmark Hill 















Actigraphy Sleep Log 
 
During the actigraphy study it will help us to interpret the results correctly if you and 
your child can complete the sleep and activity log below. It’s important to be as 
accurate as you can with the times. Please contact us with any queries, thank you. 
 
If the day was unusual or may have an effect on your child’s normal sleep pattern then 
please let us know below e.g. T=term time/H=Holidays 
Participant number: Start Date and Time 
 
 Example Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 Day 7 
Date Mon 
05/08 




































       







       
LIGHTS 
OUT 
10pm        
Sleep start 
time  







































 Example Day 8 Day 9 Day 10 Day 11 Day 12 Day 13 Day 14 
Date Mon 
05/08 






































       







       
LIGHTS 
OUT 
10pm        
Sleep start 
time  













6.30am        
 
If the day was unusual or may have an effect on your normal sleep pattern then please 




























Appendix 10: Full descriptions of Neuropsychological measures 
Wechsler Abbreviated Scale of Intelligence (WASI; Wechsler, 2011)  
The WASI-II (Wechsler, 2011) is a brief measure of general intellectual functioning which is 
comprised of 4 subtests, Block Design (BD), Vocabulary (Vc), Matrix Reasoning (MR) and 
Similarities (Si). The WASI-II gives a range of index scores representing the participants’ 
crystallised abilities, in the verbal comprehension (VCI) score, their non-verbal abilities, in the 
perceptual reasoning index (PRI) and an overall, measure of general cognitive ability, the full-
scale IQ (FSIQ). The WASI-II offers flexible administration options, comprising the measure of 
overall intelligence either from all 4, or from 2 subtests (Vc & MR). For this project, the 
subtests comprising the 2-subtest FSIQ were completed as a minimum. Subtests are scored 
using scaled scores, ranging from 1-20, with an average of 10. Indices give standard scores, 
which are scored from <60 to > 
Digit Span (WISC-IV subtest; Wechsler, 2003)  
This measure of verbal working memory is taken from the Wechsler Intelligence Scale for 
Children fourth edition (WISC-IV; Wechsler, 2003). It is comprised of two trials, digits forward 
and digits backwards. For the former, children are required to repeat a string of between 3-9 
digits, while the latter requires manipulation of number strings from 2-9, which must be 
repeated in reverse order (i.e. ‘backwards’). The subtest is scored from 1-20, with an average 
of 10. 
 
Cancellation (WISC-IV subtest; Wechsler, 2003)  
The cancellation subtest, taken from the Wechsler Intelligence Scale for Children fourth edition 
(WISC-IV; Wechsler, 2003) is a measure of processing speed. Participants have 45 seconds to 
mark selected targets (i.e. all the animals they can see among an array of target and distractor 
stimuli) on a random, and then a structured array. The subtest is scored from 1-20, with an 
average of 10. 
 
Block Recall (Working Memory Test Battery subtest; Gathercole & Pickering, 2001)  
Block Recall is a span task, taken from the Working Memory Test Battery (WMTB; Gathercole 
& Pickering, 2001), and is designed to assess visuo-spatial working memory. The stimuli consist 
of a board with nine raised blocks in what appears to the child as a “random” arrangement. 
The blocks have numbers on one side that can only be seen from the experimenter’s 
perspective. The experimenter taps a block (or series of blocks), and the child’s task is to 
duplicate the tapping in the same order as presented by the experimenter. 
California Verbal Learning Test for Children (CVLT-C; Delis et al., 1994)  
The CVLT-C (Delis et al., 1994) assesses verbal learning through an everyday memory task in 
which the child is asked to recall a list of nouns in the form of a shopping list. An interference 
task is given, followed by short-delay free recall and cued recall trials. Free recall, cued recall 
and a word recognition trial are also administered after a 20-minute delay. Raw scores for the 
task are converted into age-defined standard scores, with an increment of 0.5, ranging from -5 
to +5, with an average of 0. 
Colour-word interference (DKEFS; Delis et al., 2001) 
The Color-Word Interference Test (CWIT) from Delis-Kaplan Executive Functioning System 
(DKEFS; Delis et al., 2001), which consists of four parts: Color naming, word reading, inhibition, 
and inhibition/switching. The CWIT begins with the color naming trial, in which people are 
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presented with a page containing a series of red, green, and blue squares, and are asked to say 
the names of the colors as quickly as he/she can without making mistakes. The word reading 
trial is second, in which people are presented with a page containing the words “red,” “green,” 
and “blue” printed in black ink. People are asked to read the words aloud as quickly as he/she 
can without making mistakes. The inhibition (i.e. stroop task) trial is third, in which the patient 
is presented with a page containing the words “red,” “green,” and “blue” printed 
incongruently in red, green, or blue ink. People are asked to say the color of the ink in which 
each word is printed as quickly as he/she can without making mistakes. Last is the 
inhibition/switching trial, in which people are presented with a page containing the words 
“red,” “green,” and “blue” written in red, green, or blue ink. Half of these words are enclosed 
within boxes. People are asked to say the color of the ink in which each word is printed (as in 
the third trial), but to read the word aloud (and not name the ink color) when a word appears 
inside a box, as quickly as he/she can without making mistakes. Performance is measured by 
completion time on each of the four trials, for which raw scores are converted into age-
defined scaled scores, ranging from 1-19. 
Walk, don’t walk (TEA-Ch subtest; Manly et al., 1998)  
This subtest from the Test of Everyday Attention for Children (TEA-Ch; Manly et al., 1998) 
assesses sustained attention and response inhibition. Children are asked to take one ‘step’ 
with a pen along a paper path, after each tone they hear on a tape. Unpredictably one tone 
ends differently than the rest, signaling the child to stop. The test measures whether or not the 
child is able to stop responding when the signal occurs or is `carried away' into a task driven 
`automatic' style of responding, and/or unable to inhibit this response. Raw scores for correct 
responses are converted into age- and gender-defined scaled scores ranging from 1-19. 
Grooved Pegboard Test (Klove, 1963) 
This manipulative dexterity test contains twenty-five holes with randomly positioned slots and 
pegs which have a key along one side. Pegs must be rotated to match the hole before they can 
be inserted, and should be filled as soon as possible, without skipping any slots. Only one peg 
can be picked up at a time, and only one hand must be used. The dominant hand is tested first, 
and the test is scored by time taken to place all the pegs. 
Blending Words (CTOPP subtest; Wagner et al., 2013) 
This measure of phonological awareness, taken from the Comprehensive Test of Phonological 
Processing, second edition (CTOPP-2). A tape is played featuring words broken down into 
individual sounds (‘phonemes’). People must blend the phonemes and correctly identify the 
word. The test is scored based on number of items correctly identified, with raw scores 














Appendix 11: Full descriptions of questionnaire battery 
Conners 3rd edition (Conners-3; Conners, 2008)  
The Conners-3 is a parent-report assessment of behaviour and ADHD symptoms. It provides 
evaluation of the key areas of inattention, hyperactivity/impulsivity, learning problems, 
executive functioning, aggression, and peer relations. It is scored using age- and gender-
defined T scores.  
Strengths and Difficulties Questionnaire (SDQ; Goodman, 1997)  
The Strengths and Difficulties Questionnaire (SDQ) is a brief behavioural screening 
questionnaire about 3-16 year olds. It includes 25 items on psychological attributes, divided 
between 5 scales (emotional symptoms, conduct problems, hyperactivity/inattention, peer 
relationship problems & prosocial behaviour), and an impact supplement (which asks whether 
the respondent thinks the young person has a problem, and if so, enquire further about 
chronicity, distress, social impairment, and burden to others).   
Revised Children’s Anxiety and Depression Scale (RCADS; Chorpita et al., 2001)  
The Revised Child Anxiety and Depression Scale (RCADS) is a 47-item, youth self-report 
questionnaire with subscales including separation anxiety disorder (SAD), social phobia (SP), 
generalized anxiety disorder (GAD), panic disorder (PD), obsessive compulsive disorder (OCD), 
and major depressive disorder (MDD). It also yields a Total Anxiety Scale (sum of the 5 anxiety 
subscales) and a Total Internalizing Scale (sum of all 6 subscales). Items are rated on a 4-point 
Likert-scale from 0 (“never”) to 3 (“always”). Additionally, The Revised Child Anxiety and 
Depression Scale – Parent Version (RCADS-P) similarly assesses parent report of youth’s 
symptoms of anxiety and depression across the same six subscales. 
Paediatric Quality of Life (PedsOL; Varni et al., 1999) 
This self- and parent- report measure which asks about a young person’s physical, emotional, 
social and school functioning, with presence of problems rated on a 5-point Likert-scale from 0 
(“never”) to 4 (“almost always”). It is scored by reverse scoring and then linearly transforming 
each item onto a 0-100 scale, giving a percentage representing the young person’s quality of 



















Appendix 12: YGTSS scores for overall sample and group by recruitment source 
  
*=significant at p<.05;  
Number ratings: 0 (none), 1 (single tic), 2 (2-5 discrete tics), 3 (5 discrete tics), 4 (multiple discrete and at least one 
orchestrated pattern/sequence of tics), 5 (multiple discrete and multiple orchestrated patterns/sequences of tics).  
Frequency ratings: 0 (none), 1 (rarely present), 2 (occasionally present), 3 (frequently present), 4 (almost always 
























  TS overall (N=16) 
Mean 
(SD, Range) 













3.40 (0.98, 2-5) 
2 (1, 0-3) 
3.29 (1.26, 2-5) 
1.71 (0.96, 0-3) 
3.50 (0.75, 2-4) 
2.25 (1.03, 0-3) 
t(9.59)= -3.94, 
p=.702 






3.73 (1.03, 1-5) 
3 (1.52, 0-5) 
3.15 (1.06, 1-4) 
2.29 (1.11, 0-3) 
4.25 (0.70, 3-5) 
3.62 (1.60, 0-5) 
t(13)= -2.40, 
p=.032* 
t(13)= -1.86, p=.086 
Overall tic severity score 
(max=50) 




t(13)= -.578, p=.573 








t(13)= -.555, p-.588 
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Appendix 13: Association between sleep variables and questionnaire scores by group 
 
TS group 
Measure Rater Sleep onset latency (mins) Sleep efficiency (%) Wake after sleep onset (mins) 
SDQ: Total difficulties Self r=.333, p=.266 r=-.220, p=.470 r=-.088, p=.776 
 Parent r=.577, p=.050* r=-.454, p=.138 r=-.109, p=.736 
RCADS: Separation anxiety Self r=.600, p=.051 r=-.585, p=.059 r=-.202, p=.551 
 Parent r=.558, p=.060 r=-.417, p=.178 r=-.292, p=.356 
RCADS: Generalised anxiety Self r=.464, p=.150 r=-.439, p=.177 r=-.280, p=.405 
 Parent r=.541, p=.069 r=-.431, p=.162 r=-.145, p=.652 
RCADS: Panic disorder Self r=.639, p=.034* r=-.580, p=.061 r=-.091, p=.791 
 Parent r=.461, p=.131 r=-.265, p=.406 r=-.288, p=.363 
RCADS: Social phobia Self r=.425, p=.192 r=-.481, p=.134 r-.090, p=.793 
 Parent r=.466, p=.127 r=-.500, p=.098 r=.139, p=.666 
RCADS: OCD Self r=.546, p=.082 r=-.316, p=.344 r=-.578, p=.063 
 Parent r=.385, p=.216 r=-.154, p=.633 r=-.512, p=.089 
RCADS: Depression Self r=.473, p=.142 r=-.521, p=.100 r=.236, p=.485 
 Parent r=.630, p=.028* r=-.524, p=.080 r=-.019, p=.953 
Conner’s: Inattentive Parent r=.425, p=.168 r=-.302, p=.341 r=-.211, p=.510 
Conner’s: Hyperactive impulsive Parent r=.356, p=.256 r=-.233, p=.467 r=-.081, p=.803 
Control group 
  Sleep onset latency (mins) Sleep efficiency (%) Wake after sleep onset (mins) 
SDQ: Total difficulties Self r=.070, p=.830 r=-.129, p=.690 r=.072, p=.824 
 Parent r=-.527, p=.078 r-.379, p=.224 r=-.018, p=.956 
RCADS: Separation anxiety Self r=-.151, p=.638 r=-.049, p=.880 r=.072, p=.824 
 Parent r=-.044, p=.891 r=-.009, p=.979 r=-.178, p=.580 
RCADS: Generalised anxiety Self r=-.473, p=.120 r=.548, p=.065 r=-.389, p=.211 
 Parent r=-.365, p=.243 r=.441, p=.152 r=-.376, p=.228 
RCADS: Panic disorder Self r=-.186, p=.603 r=-.080, p=.806 r=.269, p=.398 
 Parent r=.240, p=.453 r=-.509, p=.091 r=.430, p=.163 
RCADS: Social phobia Self r=-.191, p=.552 r=-.061, p=.850 r=.310, p=.327 
 Parent r=.305, p=.335 r=-.250, p=.433 r=.060, p=.853 






























 Parent r=.043, p=.895 r=.021, p=.947 r=-.341, p=.279 
RCADS: Depression Self r=.024, p=.941 r=-.072, p=.825 r=.115, p=.722 
 Parent r=.052, p=.872 r=.029, p=.928 r=-.040, p=.902 
Conner’s: Inattentive Parent r=.160, p=.620 r=-.029, p=.929 r=-.-210, p=.513 










Cognitive Domain (Measure) Animals (Number Correct) Balloons Emotion (Commission Errors) Balloons Gender (Commission 
Errors) 
Mazes (Time To Target) 
Full Scale IQ (WASI 2 Subtest IQ) r=.317, p=.291 r=.129, p=.676 r=.067, p=.867 r=-.008, p=.979 
Working Memory: Verbal (WISC Digit 
Span) 
r=-.040, p=.896 r=-.036, p=.908 r=-.191, p=.531 r=-.117, p=.702 
Processing Speed (WISC Cancellation) r=-.639, p=.019* r=-.021, p=.945 r=.241, p=.428 r=.329, p=.273 
Inhibition (DKEFS Colour-Word 
Interference) 
r=-.100, p=.746 r=-.452, p=.121 r=-.626, p=.022* r=.230, p=.449 
Inhibition/Switching (DKEFS Colour-
Word Interference) 
r=-.016, p=.958 r=-.448, p=.125 r=-.402, p=.174 r=.436, p=.136 
Verbal Memory: Short Delay (CVLT-C) r=-.526, p=.065 r=-.323, p=.281 r=-.216, p=.478 r=.312, p=.300 
Verbal Memory: Long Delay (CVLT-C) r=-.331, p=.269 r=-.341, p=.254 r=-.190, p=.533 r=.271, p=.371 
Working Memory: Motor (WMTB Block 
Recall) 
r=.049, p=.874 r=-.145, p=.636 r=-.332, p=.268 r=-.338, p=.190 
Motor Inhibition (Tea-Ch Walk, Don’t 
Walk) 
r=.154, p=.615 r=-.094, p=.761 r=-.304, p=.313 r=-.097, p=.752 
Reaction Time (Grooved Pegboard, 
Dominant Hand) 
r=.159, p=.603 r=-.434, p=.138 r=-.058, p=.852 r=.054, p=.862 
Reaction Time (Grooved Pegboard, 
Non-Dominant Hand) 
r=-.311, p=.300 r=.213, p=.485 r=.303, p=.314 r=.597, p=.031* 
Phonological Processing (CTOPP 
Blending Words) 
r=.022, p=.945 r=.113, p=.726 r=.030, p=.926 r=-.276, p=.385 
Control 
Cognitive Measure Animals (Number Correct) Balloons Emotion (Commission Errors) Balloons Gender (Commission 
Errors) 
Mazes (Time To Target) 
Full Scale IQ (WASI 2 Subtest IQ) r=.215, p=.441 r=-.324, p=.304 r=-.146, p=.650 r=-.066, p=.822 
Working Memory: Verbal (WISC Digit 
Span) 





Processing Speed (WISC Cancellation) r=.199, p=.477 r=.032, p=.922 r=-.077, p=.812 r==.007, p=.980 
Inhibition (DKEFS Colour-Word 
Interference) 
r=.325, p=.237 r=-.325, p=.303 r=.124, p=.702 r=.058, p=.845 
Inhibition/Switching (DKEFS Colour-
Word Interference) 
r=.278, p=.315 r=-.179, p=.577 r=.253, p=.427 r=-.013, p=.965 
Verbal Memory: Short Delay (CVLT-C) r=-.434, p=.121 r=.097, p=.764 r=-.054, p=.867 r=.108, p=.726 
Verbal Memory: Long Delay (CVLT-C) r=-.360, p=.206 r=.124, p=.700 r=-.091, p=.778 r=.136, p=.657 
Working Memory: Motor (WMTB Block 
Recall) 
r=-.282, p=.328 r=.471, p=.122 r=.105, p=.745 r=-.161, p=.599 
Motor Inhibition (Tea-Ch Walk, Don’t 
Walk) 
r=.212, p=.449 r=.223, p=.485 r=-.478, p=.116 r=.220, r=.449 
Reaction Time (Grooved Pegboard, 
Dominant Hand) 
r=-.272, p=.348 r=.446, p=.146 r=-.130, p=.688 r=.151, p=.605 
Reaction Time (Grooved Pegboard, 
Non-Dominant Hand) 
r=-.176, p=.547 r=.296, r=.351 r=.197, p=.539 r=-.145, p=.622 
Phonological Processing (CTOPP 
Blending Words) 
r=.267, p=.378 r=-.375, p=.230 r=.022, p=.946 r=.043, p=.888 
